{"id":"silvadene","rwe":[{"pmid":"41889582","year":"2026","title":"A randomized open-label study comparing the safety and efficacy of a natural antimicrobial dressing with silver sulfadiazine in the management of second-degree burn wounds.","finding":"","journal":"International journal of burns and trauma","studyType":"Clinical Study"},{"pmid":"41881430","year":"2026","title":"Umbilical cord antiseptics for preventing sepsis and death among newborns.","finding":"","journal":"The Cochrane database of systematic reviews","studyType":"Clinical Study"},{"pmid":"41862967","year":"2026","title":"Efficacy and Safety of Silver Sulfadiazine Dressings and Nanocrystalline Silver Dressings on Burns: A Systematic Review and Meta-Analysis.","finding":"","journal":"Journal of clinical nursing","studyType":"Clinical Study"},{"pmid":"41842851","year":"2026","title":"Observation on the Efficacy of Nano-Silver Dressing Combined With Silver Sulfadiazine Cream in the Treatment of Second-Degree Burn Wounds.","finding":"","journal":"The Journal of craniofacial surgery","studyType":"Clinical Study"},{"pmid":"41793960","year":"2026","title":"Investıgatıon of the In vitro and In vivo effect of a mixture of Ficus carica L. and Hippophae rhamnoides L. on experımentally induced burns in rats.","finding":"","journal":"Burns : journal of the International Society for Burn Injuries","studyType":"Clinical Study"}],"_fda":{"id":"f63c800f-63a1-498e-9814-28b41de0c3b2","set_id":"0084786a-09a3-4612-9afc-6733cc0cc56a","openfda":{"nui":["N0000175503","M0020790"],"unii":["W46JY43EJR"],"route":["TOPICAL"],"rxcui":["106351"],"spl_id":["f63c800f-63a1-498e-9814-28b41de0c3b2"],"brand_name":["Silver Sulfadiazine"],"spl_set_id":["0084786a-09a3-4612-9afc-6733cc0cc56a"],"package_ndc":["63629-8773-1"],"product_ndc":["63629-8773"],"generic_name":["SILVER SULFADIAZINE"],"product_type":["HUMAN PRESCRIPTION DRUG"],"pharm_class_cs":["Sulfonamides [CS]"],"substance_name":["SILVER SULFADIAZINE"],"pharm_class_epc":["Sulfonamide Antibacterial [EPC]"],"manufacturer_name":["Bryant Ranch Prepack"],"application_number":["NDA018810"],"original_packager_product_ndc":["67877-124"]},"version":"105","warnings":["WARNINGS Absorption of silver sulfadiazine varies depending upon the percent of body surface area and the extent of the tissue damage. Although few have been reported, it is possible that any adverse reaction associated with sulfonamides may occur. Some of the reactions which have been associated with sulfonamides are as follows: blood dyscrasias including agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, and hemolytic anemia; dermatologic and allergic reactions, including life-threatening cutaneous reactions [Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and exfoliative dermatitis]; gastrointestinal reactions, hepatitis and hepatocellular necrosis; CNS reactions; and toxic nephrosis. There is a potential cross-sensitivity between silver sulfadiazine and other sulfonamides. If allergic reactions attributable to treatment with silver sulfadiazine occur, continuation of therapy must be weighed against the potential hazards of the particular allergic reaction. Fungal proliferation in and below the eschar may occur. However, the incidence of clinically reported fungal superinfection is low. The use of silver sulfadiazine cream, USP 1% in some cases of glucose-6-phosphate dehydrogenase-deficient individuals may be hazardous, as hemolysis may occur."],"pregnancy":["PREGNANCY: TERATOGENIC EFFECTS: Pregnancy Category B. A reproductive study has been performed in rabbits at doses up to three to ten times the concentration of silver sulfadiazine in silver sulfadiazine cream, USP 1% and has revealed no evidence of harm to the fetus due to silver sulfadiazine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly justified, especially in pregnant women approaching or at term. (See CONTRAINDICATIONS )"],"references":["REFERENCES Caffee F, Bingham H. Leukopenia and silver sulfadiazine. J Trauma. 1982;22: 586–587. Jarret F, Ellerbe S, Demling R. Acute leukopenia during topical burn therapy with silver sulfadiazine. Amer J Surg. 1978;135: 818–819. Kiker RG, Carvajal HF, Micak RP, Larson DL. A controlled study of the effects of silver sulfadiazine on white blood cell counts in burned children. J Trauma. 1977;17: 835–836."],"description":["DESCRIPTION Silver sulfadiazine cream, USP 1% is a soft, white, water dispersible cream containing the antimicrobial agent silver sulfadiazine in micronized form for topical application. Each gram of silver sulfadiazine cream contains 10mg of micronized silver sulfadiazine. This active agent has the following structural formula: Silver sulfadiazine cream contains 1% w/w silver sulfadiazine. The vehicle in which the active ingredient is dispersed consists of water, stearyl alcohol, white petrolatum, polyoxyl 40 stearate, propylene glycol, isopropyl myristate, and sorbitan monooleate with 0.3% methylparaben as a preservative."],"precautions":["PRECAUTIONS General. If hepatic and renal functions become impaired and elimination of the drug decreases accumulation may occur. Discontinuation of silver sulfadiazine cream, USP 1% should be weighed against the therapeutic benefit being achieved. In considering the use of topical proteolytic enzymes in conjunction with Silver sulfadiazine cream, USP 1% the possibility should be noted that silver may inactivate such enzymes. Laboratory Tests. In the treatment of burn wounds involving extensive areas of the body, the serum sulfa concentrations may approach adult therapeutic levels (8 to 12mg %). Therefore, in these patients it would be advisable to monitor serum sulfa concentrations. Renal function should be carefully monitored and the urine should be checked for sulfa crystals. Absorption of the propylene glycol vehicle has been reported to affect serum osmolality, which may affect the interpretation of laboratory tests. Carcinogenesis, Mutagenesis, Impairment of Fertility. Long-term dermal toxicity studies of 24 months duration in rats and 18 months in mice with concentrations of silver sulfadiazine three to ten times the concentration in silver sulfadiazine cream, USP 1% revealed no evidence of carcinogenicity."],"how_supplied":["HOW SUPPLIED Silver sulfadiazine cream, USP 1% - white to off-white cream NDC Number Size 63629-8773-1 400g jar Store at room temperature. 15°-30°C (59°-86°F). Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504"],"geriatric_use":["Geriatric Use. Of the total number of subjects in clinical studies of silver sulfadiazine cream, USP 1% seven percent were 65 years of age and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out."],"pediatric_use":["Pediatric Use. Safety and effectiveness in children have not been established. (See CONTRAINDICATIONS )"],"effective_time":"20250210","nursing_mothers":["Nursing Mothers. It is not known whether silver sulfadiazine cream, USP 1% is excreted in human milk. However, sulfonamides are known to be excreted in human milk and all sulfonamides derivatives are known to increase the possibility of kernicterus. Because of the possibility for serious adverse reactions in nursing infants from sulfonamides, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."],"adverse_reactions":["ADVERSE REACTIONS Several cases of transient leukopenia have been reported in patients receiving silver sulfadiazine therapy. 1,2,3 Leukopenia associated with silver sulfadiazine administration is primarily characterized by decreased neutrophil count. Maximal white blood cell depression occurs within two to four days of initiation of therapy. Rebound to normal leukocyte levels follows onset within two to three days. Recovery is not influenced by continuation of silver sulfadiazine therapy. An increased incidence has been seen in patients treated concurrently with cimetidine. Other infrequently occurring events include skin necrosis, erythema multiforme, skin discoloration, burning sensation, rashes, and interstitial nephritis. Reduction in bacterial growth after application of topical antibacterial agents has been reported to permit spontaneous healing of deep partial-thickness burns by preventing conversion of the partial thickness to full thickness by sepsis. However, reduction in bacterial colonization has caused delayed separation, in some cases necessitating escharotomy in order to prevent contracture."],"contraindications":["CONTRAINDICATIONS Silver sulfadiazine cream, USP 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. Because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, USP 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life."],"clinical_pharmacology":["CLINICAL PHARMACOLOGY Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram-negative and gram-positive bacteria as well as being effective against yeast. Results from in vitro testing are listed below. Sufficient data have been obtained to demonstrate that silver sulfadiazine will inhibit bacteria that are resistant to other antimicrobial agents and that the compound is superior to sulfadiazine. Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action of silver sulfadiazine on bacteria differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. Results of in Vitro Testing With Silver Sulfadiazine Cream, USP 1% Concentration of Silver Sulfadiazine Number of Sensitive Strains / Total Number of Strains Tested Genus and Species 50 µg/mL 100 µg/mL Pseudomonas aeruginosa 130/130 130/130 Xanthomonas (Pseudomonas) Maltophilia 7/7 7/7 Enterobacter species 48/50 50/50 Enterobacter cloacae 24/24 24/24 Klebsiella species 53/54 54/54 Escherichia coli 63/63 63/63 Serratia species 27/28 28/28 Proteus mirabilis 53/53 53/53 Morganella morganii 10/10 10/10 Providencia rettgeri 2/2 2/2 Proteus vulgaris 2/2 2/2 Providencia species 1/1 1/1 Citrobacter species 10/10 10/10 Acinetobacter calcoaceticus 10/11 11/11 Stahylococcus aureus 100/101 100/101 Staphylococcus epidermidis 51/51 51/51 β-Hemolytic Streptococcus 4/4 4/4 Enterococcus species 52/53 52/53 Corynebacterium diphtheriae 2/2 2/2 Clostridium perfringens 0/2 2/2 Candida albicans 43/50 50/50 Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated."],"indications_and_usage":["INDICATIONS AND USAGE Silver sulfadiazine cream, USP 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns."],"spl_unclassified_section":[""],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Prompt institution of appropriate regimens for care of the burned patient is of prime importance and includes the control of shock and pain. The burn wounds are then cleansed and debrided; silver sulfadiazine cream, USP 1% is then applied under sterile conditions. The burn areas should be covered with silver sulfadiazine cream, USP 1% at all times. The cream should be applied once to twice daily to a thickness of approximately one sixteenth of an inch. Whenever necessary, the cream should be reapplied to any areas from which it has been removed by patient activity. Administration may be accomplished in minimal time because dressings are not required. However, if individual patient requirements make dressings necessary, they may be used. Reapply immediately after hydrotherapy. Treatment with silver sulfadiazine cream, USP 1% should be continued until satisfactory healing has occurred or until the burn site is ready for grafting. The drug should not be withdrawn from the therapeutic regimen while there remains the possibility of infection except if a significant adverse reaction occurs."],"spl_product_data_elements":["Silver Sulfadiazine Silver Sulfadiazine SILVER SULFADIAZINE SULFADIAZINE WATER STEARYL ALCOHOL PETROLATUM POLYOXYL 40 STEARATE PROPYLENE GLYCOL ISOPROPYL MYRISTATE SORBITAN MONOOLEATE METHYLPARABEN Ascend Title Structural Formula"],"clinical_pharmacology_table":["
Results of in Vitro Testing With Silver Sulfadiazine Cream, USP 1% Concentration of Silver Sulfadiazine Number of Sensitive Strains / Total Number of Strains Tested
Genus and Species50 µg/mL100 µg/mL
Pseudomonas aeruginosa130/130130/130
Xanthomonas (Pseudomonas) Maltophilia7/77/7
Enterobacter species48/5050/50
Enterobacter cloacae24/2424/24
Klebsiella species53/5454/54
Escherichia coli63/6363/63
Serratia species27/2828/28
Proteus mirabilis53/5353/53
Morganella morganii10/1010/10
Providencia rettgeri2/22/2
Proteus vulgaris2/22/2
Providencia species1/11/1
Citrobacter species10/1010/10
Acinetobacter calcoaceticus10/1111/11
Stahylococcus aureus100/101100/101
Staphylococcus epidermidis51/5151/51
β-Hemolytic Streptococcus4/44/4
Enterococcus species52/5352/53
Corynebacterium diphtheriae2/22/2
Clostridium perfringens0/22/2
Candida albicans43/5050/50
"],"package_label_principal_display_panel":["Silver Sulfadiazine Cream 1% #400 (Jar) Label"],"carcinogenesis_and_mutagenesis_and_impairment_of_fertility":["Carcinogenesis, Mutagenesis, Impairment of Fertility. Long-term dermal toxicity studies of 24 months duration in rats and 18 months in mice with concentrations of silver sulfadiazine three to ten times the concentration in silver sulfadiazine cream, USP 1% revealed no evidence of carcinogenicity."]},"tags":[{"label":"Sulfonamide Antibacterial","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Aurora kinase A","category":"target"},{"label":"AURKA","category":"gene"},{"label":"D06BA01","category":"atc"},{"label":"Topical","category":"route"},{"label":"Cream","category":"form"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Burn Wound Infections","category":"indication"},{"label":"Minor Bacterial Skin Infections","category":"indication"},{"label":"Skin ulcer","category":"indication"},{"label":"King Pharms Llc","category":"company"},{"label":"Approved 1970s","category":"decade"},{"label":"Anti-Infective Agents","category":"pharmacology"},{"label":"Anti-Infective Agents, Local","category":"pharmacology"}],"phase":"marketed","fdaNDC":[{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8770-1","description":"50 g in 1 JAR (63629-8770-1)","marketingStartDate":"19851223"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":[],"labeler":"MACSEN DRUGS","brandName":"","packaging":[{"ndc":"73379-002-01","description":".5 kg in 1 DRUM (73379-002-01)","marketingStartDate":"18-MAR-20"},{"ndc":"73379-002-02","description":"1 kg in 1 DRUM (73379-002-02)","marketingStartDate":"18-MAR-20"},{"ndc":"73379-002-03","description":"5 kg in 1 DRUM (73379-002-03)","marketingStartDate":"18-MAR-20"},{"ndc":"73379-002-04","description":"10 kg in 1 DRUM (73379-002-04)","marketingStartDate":"18-MAR-20"},{"ndc":"73379-002-05","description":"25 kg in 1 DRUM (73379-002-05)","marketingStartDate":"18-MAR-20"}],"dosageForm":"POWDER","genericName":"silver sulfadiazine","productType":"BULK INGREDIENT","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"1 kg/kg"}],"marketingCategory":"BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING"},{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8768-1","description":"20 g in 1 TUBE (63629-8768-1)","marketingStartDate":"19851223"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8769-1","description":"25 g in 1 TUBE (63629-8769-1)","marketingStartDate":"19851223"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8771-1","description":"50 g in 1 TUBE (63629-8771-1)","marketingStartDate":"20210831"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8772-1","description":"85 g in 1 TUBE (63629-8772-1)","marketingStartDate":"19851223"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Bryant Ranch Prepack","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63629-8773-1","description":"400 g in 1 JAR (63629-8773-1)","marketingStartDate":"20210831"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"50090-2152-0","description":"400 g in 1 JAR (50090-2152-0)","marketingStartDate":"20151021"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Proficient Rx LP","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"63187-023-25","description":"25 g in 1 TUBE (63187-023-25)","marketingStartDate":"20181101"},{"ndc":"63187-023-51","description":"50 g in 1 TUBE (63187-023-51)","marketingStartDate":"20240214"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Advanced Rx Pharmacy of Tennessee, LLC","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"80425-0221-1","description":"50 g in 1 TUBE (80425-0221-1)","marketingStartDate":"20230112"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":[],"labeler":"Spectrum Laboratory Products, Inc.","brandName":"","packaging":[{"ndc":"49452-6545-1","description":"10 g in 1 BOTTLE (49452-6545-1)","marketingStartDate":"01-MAY-95"},{"ndc":"49452-6545-2","description":"100 g in 1 BOTTLE (49452-6545-2)","marketingStartDate":"01-MAY-95"},{"ndc":"49452-6545-3","description":"1000 g in 1 PAIL (49452-6545-3)","marketingStartDate":"01-MAY-95"},{"ndc":"49452-6545-4","description":"25 g in 1 BOTTLE (49452-6545-4)","marketingStartDate":"01-MAY-95"},{"ndc":"49452-6545-5","description":"5000 g in 1 PAIL (49452-6545-5)","marketingStartDate":"01-MAY-95"}],"dosageForm":"POWDER","genericName":"Silver Sulfadiazine","productType":"BULK INGREDIENT","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"1 g/g"}],"marketingCategory":"BULK INGREDIENT"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"SSD","packaging":[{"ndc":"50090-7447-0","description":"50 g in 1 JAR (50090-7447-0)","marketingStartDate":"20241107"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Preferred Pharmaceuticals Inc.","brandName":"SSD Cream","packaging":[{"ndc":"68788-8074-2","description":"25 g in 1 TUBE (68788-8074-2)","marketingStartDate":"20210827"},{"ndc":"68788-8074-5","description":"50 g in 1 TUBE (68788-8074-5)","marketingStartDate":"20210827"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Asclemed USA, Inc.","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"87063-078-05","description":"50 g in 1 TUBE (87063-078-05)","marketingStartDate":"20260123"},{"ndc":"87063-078-10","description":"1000 g in 1 JAR (87063-078-10)","marketingStartDate":"20260123"},{"ndc":"87063-078-20","description":"20 g in 1 TUBE (87063-078-20)","marketingStartDate":"20260123"},{"ndc":"87063-078-25","description":"25 g in 1 TUBE (87063-078-25)","marketingStartDate":"20260123"},{"ndc":"87063-078-40","description":"400 g in 1 JAR (87063-078-40)","marketingStartDate":"20260123"},{"ndc":"87063-078-50","description":"50 g in 1 JAR (87063-078-50)","marketingStartDate":"20260123"},{"ndc":"87063-078-85","description":"85 g in 1 TUBE (87063-078-85)","marketingStartDate":"20260123"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":[],"labeler":"Lusochimica SPA","brandName":"","packaging":[{"ndc":"43898-0134-0","description":"25 kg in 1 DRUM (43898-0134-0)","marketingStartDate":"19-OCT-18"}],"dosageForm":"POWDER","genericName":"Silver Sulfadiazine","productType":"BULK INGREDIENT","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"1 kg/kg"}],"marketingCategory":"BULK INGREDIENT"},{"route":["TOPICAL"],"labeler":"Ascend Laboratories, LLC","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"67877-124-05","description":"50 g in 1 TUBE (67877-124-05)","marketingStartDate":"19851223"},{"ndc":"67877-124-10","description":"1000 g in 1 JAR (67877-124-10)","marketingStartDate":"19851223"},{"ndc":"67877-124-20","description":"20 g in 1 TUBE (67877-124-20)","marketingStartDate":"19851223"},{"ndc":"67877-124-25","description":"25 g in 1 TUBE (67877-124-25)","marketingStartDate":"19851223"},{"ndc":"67877-124-40","description":"400 g in 1 JAR (67877-124-40)","marketingStartDate":"19851223"},{"ndc":"67877-124-50","description":"50 g in 1 JAR (67877-124-50)","marketingStartDate":"19851223"},{"ndc":"67877-124-85","description":"85 g in 1 TUBE (67877-124-85)","marketingStartDate":"19851223"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Dr Reddys Laboratories Inc","brandName":"SSD Cream","packaging":[{"ndc":"43598-210-25","description":"25 g in 1 TUBE (43598-210-25)","marketingStartDate":"20110504"},{"ndc":"43598-210-40","description":"400 g in 1 JAR (43598-210-40)","marketingStartDate":"20110504"},{"ndc":"43598-210-50","description":"50 g in 1 TUBE (43598-210-50)","marketingStartDate":"20110504"},{"ndc":"43598-210-55","description":"50 g in 1 JAR (43598-210-55)","marketingStartDate":"20110504"},{"ndc":"43598-210-85","description":"85 g in 1 TUBE (43598-210-85)","marketingStartDate":"20110504"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"DIRECT RX","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"61919-237-25","description":"25 g in 1 TUBE (61919-237-25)","marketingStartDate":"20150101"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"SILVADENE","packaging":[{"ndc":"50090-0230-0","description":"1 TUBE in 1 CARTON (50090-0230-0) / 20 g in 1 TUBE","marketingStartDate":"20160629"}],"dosageForm":"CREAM","genericName":"silver sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":[],"labeler":"TAPI Croatia Industries Ltd.","brandName":"","packaging":[{"ndc":"11722-021-00","description":"1 kg in 1 CARTON (11722-021-00)","marketingStartDate":"17-JAN-13"}],"dosageForm":"POWDER","genericName":"Silver Sulfadiazine","productType":"BULK INGREDIENT","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"100 kg/100kg"}],"marketingCategory":"BULK INGREDIENT"},{"route":["TOPICAL"],"labeler":"Mylan Pharmaceuticals Inc.","brandName":"SILVER SULFADIAZINE","packaging":[{"ndc":"59762-0131-0","description":"1 TUBE in 1 CARTON (59762-0131-0) / 20 g in 1 TUBE","marketingStartDate":"20180209"},{"ndc":"59762-0131-2","description":"1 TUBE in 1 CARTON (59762-0131-2) / 25 g in 1 TUBE","marketingStartDate":"20180209"},{"ndc":"59762-0131-4","description":"400 g in 1 JAR (59762-0131-4)","marketingStartDate":"20180116"},{"ndc":"59762-0131-5","description":"1 TUBE in 1 CARTON (59762-0131-5) / 50 g in 1 TUBE","marketingStartDate":"20180116"},{"ndc":"59762-0131-6","description":"50 g in 1 JAR (59762-0131-6)","marketingStartDate":"20180116"},{"ndc":"59762-0131-8","description":"1 TUBE in 1 CARTON (59762-0131-8) / 85 g in 1 TUBE","marketingStartDate":"20180116"}],"dosageForm":"CREAM","genericName":"silver sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA AUTHORIZED GENERIC"},{"route":["TOPICAL"],"labeler":"Preferred Pharmaceuticals, Inc.","brandName":"Thermazene Silver Sulfadiazine","packaging":[{"ndc":"68788-0600-2","description":"25 g in 1 TUBE (68788-0600-2)","marketingStartDate":"20151116"},{"ndc":"68788-0600-4","description":"400 g in 1 JAR (68788-0600-4)","marketingStartDate":"20161004"},{"ndc":"68788-0600-5","description":"50 g in 1 JAR (68788-0600-5)","marketingStartDate":"20130904"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Asclemed USA, Inc.","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"76420-208-25","description":"25 g in 1 TUBE (76420-208-25)","marketingStartDate":"20220309"},{"ndc":"76420-208-50","description":"50 g in 1 TUBE (76420-208-50)","marketingStartDate":"20220309"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"NuCare Pharmaceuticals, Inc.","brandName":"SSD Cream","packaging":[{"ndc":"68071-3867-5","description":"50 g in 1 TUBE (68071-3867-5)","marketingStartDate":"20250613"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"Pfizer Laboratories Div Pfizer Inc","brandName":"SILVADENE","packaging":[{"ndc":"61570-131-20","description":"1 TUBE in 1 CARTON (61570-131-20) / 20 g in 1 TUBE","marketingStartDate":"19731126"},{"ndc":"61570-131-25","description":"1 TUBE in 1 CARTON (61570-131-25) / 25 g in 1 TUBE","marketingStartDate":"20150526"},{"ndc":"61570-131-40","description":"400 g in 1 JAR (61570-131-40)","marketingStartDate":"19731126"},{"ndc":"61570-131-50","description":"50 g in 1 JAR (61570-131-50)","marketingStartDate":"19731126"},{"ndc":"61570-131-55","description":"1 TUBE in 1 CARTON (61570-131-55) / 50 g in 1 TUBE","marketingStartDate":"20150526"},{"ndc":"61570-131-85","description":"1 TUBE in 1 CARTON (61570-131-85) / 85 g in 1 TUBE","marketingStartDate":"19731126"},{"ndc":"61570-131-98","description":"1000 g in 1 JAR (61570-131-98)","marketingStartDate":"19731126"}],"dosageForm":"CREAM","genericName":"silver sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"50090-0607-0","description":"50 g in 1 JAR (50090-0607-0)","marketingStartDate":"20141128"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"50090-0717-0","description":"50 g in 1 TUBE (50090-0717-0)","marketingStartDate":"20141128"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"ST. MARY'S MEDICAL PARK PHARMACY","brandName":"SSD Cream","packaging":[{"ndc":"60760-962-50","description":"50 g in 1 TUBE (60760-962-50)","marketingStartDate":"20241004"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 g/1000g"}],"marketingCategory":"NDA"},{"route":["TOPICAL"],"labeler":"A-S Medication Solutions","brandName":"Silver Sulfadiazine","packaging":[{"ndc":"50090-0763-0","description":"25 g in 1 TUBE (50090-0763-0)","marketingStartDate":"20141128"}],"dosageForm":"CREAM","genericName":"Silver Sulfadiazine","productType":"HUMAN PRESCRIPTION DRUG","activeIngredients":[{"name":"SILVER SULFADIAZINE","strength":"10 mg/g"}],"marketingCategory":"NDA"}],"safety":{"safetySignals":[{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"151 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"147 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"141 reports"},{"date":"","signal":"PRODUCT USE IN UNAPPROVED INDICATION","source":"FDA FAERS","actionTaken":"135 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"133 reports"},{"date":"","signal":"DEATH","source":"FDA FAERS","actionTaken":"122 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"115 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"109 reports"},{"date":"","signal":"CHRONIC KIDNEY DISEASE","source":"FDA FAERS","actionTaken":"107 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"102 reports"},{"date":"","signal":"RASH","source":"FDA FAERS","actionTaken":"97 reports"},{"date":"","signal":"ANXIETY","source":"FDA FAERS","actionTaken":"95 reports"},{"date":"","signal":"PNEUMONIA","source":"FDA FAERS","actionTaken":"93 reports"},{"date":"","signal":"ACUTE KIDNEY INJURY","source":"FDA FAERS","actionTaken":"90 reports"},{"date":"","signal":"FALL","source":"FDA FAERS","actionTaken":"90 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"88 reports"},{"date":"","signal":"ASTHENIA","source":"FDA FAERS","actionTaken":"85 reports"},{"date":"","signal":"DRUG HYPERSENSITIVITY","source":"FDA FAERS","actionTaken":"81 reports"},{"date":"","signal":"RENAL FAILURE","source":"FDA FAERS","actionTaken":"80 reports"},{"date":"","signal":"ARTHRALGIA","source":"FDA FAERS","actionTaken":"79 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"73 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"72 reports"},{"date":"","signal":"PAIN IN EXTREMITY","source":"FDA FAERS","actionTaken":"69 reports"},{"date":"","signal":"CELLULITIS","source":"FDA FAERS","actionTaken":"65 reports"},{"date":"","signal":"CONDITION AGGRAVATED","source":"FDA FAERS","actionTaken":"63 reports"},{"date":"","signal":"ANAEMIA","source":"FDA FAERS","actionTaken":"61 reports"},{"date":"","signal":"BACK PAIN","source":"FDA FAERS","actionTaken":"61 reports"},{"date":"","signal":"PYREXIA","source":"FDA FAERS","actionTaken":"61 reports"},{"date":"","signal":"WEIGHT DECREASED","source":"FDA FAERS","actionTaken":"60 reports"},{"date":"","signal":"PRURITUS","source":"FDA FAERS","actionTaken":"56 reports"},{"date":"","signal":"URINARY TRACT INFECTION","source":"FDA FAERS","actionTaken":"55 reports"},{"date":"","signal":"DEPRESSION","source":"FDA FAERS","actionTaken":"54 reports"},{"date":"","signal":"COUGH","source":"FDA FAERS","actionTaken":"53 reports"},{"date":"","signal":"DECREASED APPETITE","source":"FDA FAERS","actionTaken":"53 reports"},{"date":"","signal":"CONSTIPATION","source":"FDA FAERS","actionTaken":"52 reports"},{"date":"","signal":"BLISTER","source":"FDA FAERS","actionTaken":"51 reports"},{"date":"","signal":"EMOTIONAL DISTRESS","source":"FDA FAERS","actionTaken":"50 reports"},{"date":"","signal":"SEPSIS","source":"FDA FAERS","actionTaken":"50 reports"},{"date":"","signal":"SKIN ULCER","source":"FDA FAERS","actionTaken":"50 reports"},{"date":"","signal":"DEHYDRATION","source":"FDA FAERS","actionTaken":"49 reports"},{"date":"","signal":"MALAISE","source":"FDA FAERS","actionTaken":"49 reports"},{"date":"","signal":"ABDOMINAL PAIN","source":"FDA FAERS","actionTaken":"48 reports"},{"date":"","signal":"OEDEMA PERIPHERAL","source":"FDA FAERS","actionTaken":"48 reports"},{"date":"","signal":"HYPOTENSION","source":"FDA FAERS","actionTaken":"47 reports"},{"date":"","signal":"PERIPHERAL SWELLING","source":"FDA FAERS","actionTaken":"47 reports"},{"date":"","signal":"HYPERTENSION","source":"FDA FAERS","actionTaken":"46 reports"},{"date":"","signal":"SKIN DISCOLOURATION","source":"FDA FAERS","actionTaken":"45 reports"},{"date":"","signal":"INSOMNIA","source":"FDA FAERS","actionTaken":"42 reports"},{"date":"","signal":"CARDIAC FAILURE CONGESTIVE","source":"FDA FAERS","actionTaken":"41 reports"},{"date":"","signal":"MUSCLE SPASMS","source":"FDA FAERS","actionTaken":"40 reports"}],"drugInteractions":[{"drug":"Cimetidine","severity":"moderate","mechanism":"Unknown","management":"Monitor white blood cell count if used concurrently","clinicalEffect":"Increased incidence of leukopenia"}],"commonSideEffects":[{"effect":"Injection site erythema","drugRate":"76.1%","placeboRate":"","totalAtRisk":46,"totalAffected":35,"trialsReporting":1},{"effect":"Injection site pain","drugRate":"50.0%","placeboRate":"","totalAtRisk":46,"totalAffected":23,"trialsReporting":1},{"effect":"Injection site swelling","drugRate":"45.7%","placeboRate":"","totalAtRisk":46,"totalAffected":21,"trialsReporting":1},{"effect":"Headache","drugRate":"26.1%","placeboRate":"","totalAtRisk":46,"totalAffected":12,"trialsReporting":1},{"effect":"Injection site pruritus","drugRate":"17.4%","placeboRate":"","totalAtRisk":46,"totalAffected":8,"trialsReporting":1},{"effect":"Injection site discolouration","drugRate":"15.2%","placeboRate":"","totalAtRisk":46,"totalAffected":7,"trialsReporting":1},{"effect":"Injection site pallor","drugRate":"13.0%","placeboRate":"","totalAtRisk":46,"totalAffected":6,"trialsReporting":1},{"effect":"Injection site haemorrhage","drugRate":"10.9%","placeboRate":"","totalAtRisk":46,"totalAffected":5,"trialsReporting":1},{"effect":"Myalgia","drugRate":"10.9%","placeboRate":"","totalAtRisk":46,"totalAffected":5,"trialsReporting":1},{"effect":"Injection site warmth","drugRate":"6.5%","placeboRate":"","totalAtRisk":46,"totalAffected":3,"trialsReporting":1},{"effect":"Pyrexia","drugRate":"6.5%","placeboRate":"","totalAtRisk":46,"totalAffected":3,"trialsReporting":1},{"effect":"Nausea","drugRate":"6.5%","placeboRate":"","totalAtRisk":46,"totalAffected":3,"trialsReporting":1},{"effect":"Back pain","drugRate":"6.5%","placeboRate":"","totalAtRisk":46,"totalAffected":3,"trialsReporting":1},{"effect":"Injection site bruising","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"Chills","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site nodule","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"Presyncope","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"Nasopharyngitis","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"C-reactive protein increased","drugRate":"4.3%","placeboRate":"","totalAtRisk":46,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site inflammation","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Fatigue","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Medical device site dermatitis","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Dizziness","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Syncope","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Aphthous ulcer","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Dyspepsia","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Bacterial vaginosis","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Paronychia","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Vulvovaginal mycotic infection","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Contusion","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Ligament sprain","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Muscle strain","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Skin abrasion","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Epistaxis","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Dermatitis atopic","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Drug eruption","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Photosensitivity reaction","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Thrombocytopenia","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Drug hypersensitivity","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Allergy to arthropod sting","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Decreased appetite","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Conjunctival hyperaemia","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Vision blurred","drugRate":"2.2%","placeboRate":"","totalAtRisk":46,"totalAffected":1,"trialsReporting":1},{"effect":"Feeling of body temperature change","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1},{"effect":"Influenza like illness","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site dermatitis","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site discomfort","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site exfoliation","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1},{"effect":"Injection site paraesthesia","drugRate":"0.0%","placeboRate":"","totalAtRisk":46,"totalAffected":0,"trialsReporting":1}],"contraindications":["Hypersensitivity to silver sulfadiazine or any other ingredients in the preparation","Pregnant women approaching or at term","Premature infants","Newborn infants during the first 2 months of life"],"specialPopulations":{"Nursing":"Nursing Mothers. It is not known whether silver sulfadiazine cream, USP 1% is excreted in human milk. However, sulfonamides are known to be excreted in human milk and all sulfonamides derivatives are known to increase the possibility of kernicterus. Because of the possibility for serious adverse reactions in nursing infants from sulfonamides, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.","Geriatric":"Geriatric Use. Of the total number of subjects in clinical studies of silver sulfadiazine cream, USP 1% seven percent were 65 years of age and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.","Pediatric":"Pediatric Use. Safety and effectiveness in children have not been established. (See CONTRAINDICATIONS )","Pregnancy":"PREGNANCY: TERATOGENIC EFFECTS: Pregnancy Category B. A reproductive study has been performed in rabbits at doses up to three to ten times the concentration of silver sulfadiazine in silver sulfadiazine cream, USP 1% and has revealed no evidence of harm to the fetus due to silver sulfadiazine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy onl"},"seriousAdverseEvents":[]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$0.0786/GM","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$29","description":"SILVER SULFADIAZINE 1% CREAM","retrievedDate":"2026-04-07"}],"_sources":{"fdaNDC":{"url":"","method":"api_direct","source":"FDA NDC Directory","rawText":"","confidence":1,"sourceType":"fda_ndc","retrievedAt":"2026-04-19T21:12:05.885470+00:00"},"patents":{"url":"","method":"deterministic","source":"FDA Orange Book + Purple Book","rawText":"","confidence":1,"sourceType":"fda_orange_book","retrievedAt":"2026-04-19T21:12:19.826190+00:00"},"dailyMed":{"url":"","method":"api_direct","source":"DailyMed (NIH/NLM)","rawText":"","confidence":1,"sourceType":"dailymed","retrievedAt":"2026-04-19T21:12:06.591700+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"Haiku strategic summary","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T07:54:57.252797+00:00"},"mechanism":{"url":"","method":"ai_extraction","source":"FDA Label + Haiku","rawText":"","confidence":0.95,"sourceType":"fda_label","retrievedAt":"2026-04-20T08:26:57.271505+00:00"},"chemblData":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1382627/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T21:12:12.927768+00:00"},"howSupplied":{"url":"","method":"deterministic","source":"FDA Label (how_supplied)","rawText":"HOW SUPPLIED Silver sulfadiazine cream, USP 1% - white to off-white cream NDC Number Size 63629-8773-1 400g jar Store at room temperature. 15°-30°C (59°-86°F). Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T21:11:50.435080+00:00"},"trialDetails":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (0 trials with endpoints)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T21:12:29.101580+00:00"},"drugDescription":{"url":"","method":"ai_extraction","source":"FDA Label (description)","aiModel":"featherless","rawText":"DESCRIPTION Silver sulfadiazine cream, USP 1% is a soft, white, water dispersible cream containing the antimicrobial agent silver sulfadiazine in micronized form for topical application. Each gram of silver sulfadiazine cream contains 10mg of micronized silver sulfadiazine. This active agent has the following structural formula: Silver sulfadiazine cream contains 1% w/w silver sulfadiazine. The vehicle in which the active ingredient is dispersed consists of water, stearyl alcohol, white petrolat","confidence":0.95,"sourceType":"fda_label","retrievedAt":"2026-04-19T21:11:59.267338+00:00"},"pharmacokinetics":{"url":"","method":"ai_extraction","source":"FDA Label (pharmacokinetics)","aiModel":"featherless","rawText":"CLINICAL PHARMACOLOGY Silver sulfadiazine has broad antimicrobial activity. It is bactericidal for many gram-negative and gram-positive bacteria as well as being effective against yeast. Results from in vitro testing are listed below. Sufficient data have been obtained to demonstrate that silver sulfadiazine will inhibit bacteria that are resistant to other antimicrobial agents and that the compound is superior to sulfadiazine. Studies utilizing radioactive micronized silver sulfadiazine, electr","confidence":0.95,"sourceType":"fda_label","retrievedAt":"2026-04-19T21:11:50.435009+00:00"},"publicationCount":{"url":"","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T21:12:11.583362+00:00"},"faersTotalReports":{"url":"","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T21:12:11.092282+00:00"},"recentPublications":{"url":"","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T21:12:12.557261+00:00"},"rxnormFormulations":{"url":"https://rxnav.nlm.nih.gov/REST/drugs.json?name=Silver Sulfadiazine","method":"api_direct","source":"RxNorm (NIH)","rawText":"","confidence":1,"sourceType":"rxnorm","retrievedAt":"2026-04-19T21:12:05.474651+00:00"},"participantFlowData":{"url":"","method":"deterministic","source":"ClinicalTrials.gov participantFlowModule","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T21:12:29.101512+00:00"},"safety.safetySignals":{"url":"","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-19T21:12:07.487245+00:00"},"nonclinicalToxicology":{"url":"","method":"deterministic","source":"FDA Label (nonclinical_toxicology)","rawText":"Carcinogenesis, Mutagenesis, Impairment of Fertility. Long-term dermal toxicity studies of 24 months duration in rats and 18 months in mice with concentrations of silver sulfadiazine three to ten times the concentration in silver sulfadiazine cream, USP 1% revealed no evidence of carcinogenicity.","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T21:11:59.267418+00:00"},"structuredTrialResults":{"url":"","method":"deterministic","source":"ClinicalTrials.gov resultsSection (0 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T21:12:29.101510+00:00"},"safety.drugInteractions":{"url":"","method":"ai_extraction","source":"FDA Label + Haiku","rawText":"","confidence":0.95,"sourceType":"fda_label","retrievedAt":"2026-04-20T07:54:57.252792+00:00"},"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (0 trials with results)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T21:12:29.101410+00:00"},"safety.contraindications":{"url":"","method":"ai_extraction","source":"FDA Label + Haiku","rawText":"","confidence":0.95,"sourceType":"fda_label","retrievedAt":"2026-04-20T07:54:57.252770+00:00"},"safety.specialPopulations":{"url":"","method":"deterministic","source":"FDA Label (special populations)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-19T21:11:59.267456+00:00"},"safety.seriousAdverseEvents":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (0 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-19T21:12:29.101434+00:00"}},"allNames":["sulfadiazine silver","silvadene","silver sulfadiazine","sulfadiazine, silver"],"dailyMed":[{"url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef0cf79-e960-44a6-acac-797913b71c97","setid":"7ef0cf79-e960-44a6-acac-797913b71c97","title":"SILVER SULFADIAZINE CREAM [DIRECT RX]"},{"url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42c3ece4-0df0-4ed8-ac0f-a65fad19eed7","setid":"42c3ece4-0df0-4ed8-ac0f-a65fad19eed7","title":"THERMAZENE SILVER SULFADIAZINE (SILVER SULFADIAZINE) CREAM [PREFERRED PHARMACEUTICALS, INC.]"},{"url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d9aa72e-b8dc-4ea3-be44-80f03ba81982","setid":"4d9aa72e-b8dc-4ea3-be44-80f03ba81982","title":"SILVER SULFADIAZINE CREAM [ASCLEMED USA, INC.]"},{"url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c437213a-1cd4-445e-a39f-bbcacb9f746f","setid":"c437213a-1cd4-445e-a39f-bbcacb9f746f","title":"SILVADENE (SILVER SULFADIAZINE) CREAM [PFIZER LABORATORIES DIV PFIZER INC]"},{"url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef7ff8fc-4dad-42b4-9c3e-b3f4f80b5e73","setid":"ef7ff8fc-4dad-42b4-9c3e-b3f4f80b5e73","title":"ENROFLOXACIN AND SILVER SULFADIAZINE OTIC EMULSION (ENROFLOXACIN/SILVER SULFADIAZINE) EMULSION [COVETRUS]"}],"offLabel":[],"synonyms":["sulfadiazine silver","silvadene","silver sulfadiazine","sulfadiazine, silver"],"timeline":[{"date":"1973-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from KING PHARMS to King Pharms Llc"},{"date":"1973-11-26","type":"positive","source":"DrugCentral","milestone":"FDA approval (King Pharms)"},{"date":"1982-02-25","type":"positive","source":"FDA Orange Book","milestone":"Ssd approved — 1%"},{"date":"1985-12-23","type":"positive","source":"FDA Orange Book","milestone":"Thermazene approved — 1%"},{"date":"1989-11-30","type":"positive","source":"FDA Orange Book","milestone":"Sildaflo approved — 1%"}],"aiSummary":"Silver sulfadiazine cream 1% is a topical antimicrobial indicated as an adjunct for prevention and treatment of wound sepsis in second and third degree burns. It demonstrates broad bactericidal activity against gram-negative and gram-positive bacteria and yeast through cell membrane and wall disruption. Contraindications include hypersensitivity and use in pregnant women at term, premature infants, and newborns under 2 months due to kernicterus risk from sulfonamide therapy. The agent offers clinical utility in burn wound management with superior efficacy compared to sulfadiazine alone.","brandName":"Silvadene","ecosystem":[{"indication":"Burn Wound Infections","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"erythromycin ethyl succinate","slug":"erythromycin-ethyl-succinate","company":"Arbor Pharms Llc"},{"name":"gentamicin","slug":"gentamicin","company":"Schering"},{"name":"kanamycin","slug":"kanamycin","company":"Apothecon"}],"globalPrevalence":null},{"indication":"Minor Bacterial Skin Infections","otherDrugs":[{"name":"Polymyxin B","slug":"polymyxin-b","company":"Monarch Pharms"},{"name":"bacitracin","slug":"bacitracin","company":"Pharmacia And Upjohn"},{"name":"chlortetracycline","slug":"chlortetracycline","company":""},{"name":"cortisone acetate","slug":"cortisone-acetate","company":""}],"globalPrevalence":null},{"indication":"Skin ulcer","otherDrugs":[{"name":"sulfadiazine","slug":"sulfadiazine","company":"Lederle"}],"globalPrevalence":null}],"mechanism":{"target":"bacterial cell membrane and cell wall","novelty":"Follow-on","targets":[{"gene":"AURKA","source":"DrugCentral","target":"Aurora kinase A","protein":"Aurora kinase A"}],"modality":"topical","drugClass":"sulfonamide antimicrobial","explanation":"Silver sulfadiazine has broad antimicrobial activity and is bactericidal for many gram-negative and gram-positive bacteria as well as being effective against yeast. Studies utilizing radioactive micronized silver sulfadiazine, electron microscopy, and biochemical techniques have revealed that the mechanism of action differs from silver nitrate and sodium sulfadiazine. Silver sulfadiazine acts only on the cell membrane and cell wall to produce its bactericidal effect. The compound is superior to sulfadiazine and will inhibit bacteria that are resistant to other antimicrobial agents. Silver sulfadiazine is not a carbonic anhydrase inhibitor and may be useful in situations where such agents are contraindicated.","oneSentence":"Silver sulfadiazine acts on bacterial cell membrane and cell wall to produce bactericidal effect.","technicalDetail":"Silvadene's mechanism of action involves the release of silver ions, which have broad-spectrum antimicrobial activity, and the inhibition of bacterial DNA synthesis by sulfadiazine, a sulfonamide antibacterial agent."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Silver_sulfadiazine","title":"Silver sulfadiazine","extract":"Silver sulfadiazine, sold under the brand Silvadene among others, is a topical antibiotic used in partial thickness and full thickness burns to prevent infection. Tentative evidence has found other antibiotics to be more effective, and therefore it is no longer generally recommended for second-degree (partial-thickness) burns, but is still widely used to protect third-degree (full-thickness) burns."},"chemblData":{"prodrug":0,"chemblId":"CHEMBL1382627","maxPhase":"4.0","chirality":2,"parenteral":false,"availability":1,"moleculeType":"Small molecule","withdrawnFlag":false,"naturalProduct":0,"blackBoxWarning":0,"oralBioavailable":false},"commercial":{"launchDate":"1973","_launchSource":"DrugCentral (FDA 1973-11-26, KING PHARMS)"},"fdaRecalls":[],"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4142","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=Silver%20Sulfadiazine","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Silver Sulfadiazine","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Silver_sulfadiazine","fields":["history","overview"],"source":"Wikipedia"},{"id":5,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T01:43:51.692643","_validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:27:01.952015+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"sulfathiazole","drugSlug":"sulfathiazole","fdaApproval":"1945-09-12","relationship":"same-class"},{"drugName":"mafenide","drugSlug":"mafenide","fdaApproval":"1969-01-24","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulfamethizole","drugSlug":"sulfamethizole","fdaApproval":"1953-10-28","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulfanilamide","drugSlug":"sulfanilamide","fdaApproval":"1965-06-05","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"sulfamerazine","drugSlug":"sulfamerazine","fdaApproval":"1949-08-16","relationship":"same-class"}],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"},{"url":"https://tavily.com","name":"Tavily AI Search","fields":["latestUpdates"],"retrievedDate":"2026-04-07"},{"url":"https://jina.ai/reader","name":"Jina Reader","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"},{"url":"https://groq.com","name":"Groq (Llama 3.1 8B)","fields":["commercialAnalysis"],"retrievedDate":"2026-04-07"}],"genericName":"silver sulfadiazine","howSupplied":"HOW SUPPLIED Silver sulfadiazine cream, USP 1% - white to off-white cream NDC Number Size 63629-8773-1 400g jar Store at room temperature. 15°-30°C (59°-86°F). Repackaged/Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504","indications":{"approved":[{"name":"Burn Wound Infections","source":"DrugCentral","snomedId":"","regulator":"FDA","eligibility":"patients with second and third degree burns"},{"name":"Minor Bacterial Skin Infections","source":"DrugCentral","snomedId":"","regulator":"FDA","eligibility":"no information available"},{"name":"Skin ulcer","source":"DrugCentral","snomedId":46742003,"regulator":"FDA","eligibility":"no information available"}],"offLabel":[],"pipeline":[]},"currentOwner":"King Pharms Llc","drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"sulfathiazole","brandName":"sulfathiazole","genericName":"sulfathiazole","approvalYear":"1945","relationship":"same-class"},{"drugId":"mafenide","brandName":"mafenide","genericName":"mafenide","approvalYear":"1969","relationship":"same-class"},{"drugId":"sulfamethizole","brandName":"sulfamethizole","genericName":"sulfamethizole","approvalYear":"1953","relationship":"same-class"},{"drugId":"sulfanilamide","brandName":"sulfanilamide","genericName":"sulfanilamide","approvalYear":"1965","relationship":"same-class"},{"drugId":"sulfamerazine","brandName":"sulfamerazine","genericName":"sulfamerazine","approvalYear":"1949","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[{"url":"https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.html","date":"2026-04-07","type":"news","title":"Topical Drug Delivery Market Report 2025-2030, By ...","source":"www.marketsandmarkets.com"},{"url":"https://www.industryarc.com/Report/16242/silver-sulfadiazine-market-research","date":"2026-04-07","type":"news","title":"Silver Sulfadiazine Market - Forecast(2026","source":"www.industryarc.com"},{"url":"https://www.coherentmarketinsights.com/industry-reports/sulfonamides-market","date":"2026-04-07","type":"news","title":"Sulfonamides Market Size, Share and Forecast, 2025-2032","source":"www.coherentmarketinsights.com"},{"url":"https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/017381Orig1s050ltr.pdf","date":"2026-04-07","type":"news","title":"[PDF] Silvadene (silver sulfadiazine) Cream, 1%. - accessdata.fda.gov","source":"www.accessdata.fda.gov"},{"url":"https://cdn.pfizer.com/pfizercom/product-pipeline/Q1_2025_Pipeline_Update_29APR2025.pdf?VersionId=7hjVCBiYrHhTyTEE1tgA5DD8Hp4qB0vo","date":"2026-04-07","type":"news","title":"[PDF] 5 - Pfizer Pipeline","source":"cdn.pfizer.com"}],"manufacturing":[],"administration":{"route":"Topical","formulation":"Cream","formulations":[{"form":"CREAM","route":"TOPICAL","productName":"Silver Sulfadiazine"},{"form":"CREAM","route":"TOPICAL","productName":"SILVADENE"},{"form":"CREAM","route":"TOPICAL","productName":"SILVER SULFADIAZINE"},{"form":"CREAM","route":"TOPICAL","productName":"SSD"},{"form":"CREAM","route":"TOPICAL","productName":"SSD Cream"},{"form":"CREAM","route":"TOPICAL","productName":"Silver Sulfadiazene"},{"form":"CREAM","route":"TOPICAL","productName":"Silver Sulfadiazine"},{"form":"CREAM","route":"TOPICAL","productName":"Thermazene"},{"form":"CREAM","route":"TOPICAL","productName":"ThermazeneSilver Sulfadiazine"},{"form":"CREAM","route":"TOPICAL","productName":"SILVER SULFADIAZINE"}]},"_patentsChecked":true,"crossReferences":{"NUI":"N0000146826","MMSL":"1640","NDDF":"003135","UNII":"W46JY43EJR","VUID":"4018504","CHEBI":"CHEBI:9142","VANDF":"4018504","RXNORM":"224926","UMLSCUI":"C0037134","chemblId":"CHEMBL1382627","ChEMBL_ID":"CHEMBL1382627","KEGG_DRUG":"D00433","DRUGBANK_ID":"DB05245","PUBCHEM_CID":"441244","SNOMEDCT_US":"19630009","MESH_DESCRIPTOR_UI":"D012837"},"drugDescription":{"pH":"","structure":"The active agent has the following structural formula: [Not provided in text]","appearance":"A soft, white, water dispersible cream","composition":"Each gram of silver sulfadiazine cream contains 10mg of micronized silver sulfadiazine. The vehicle consists of water, stearyl alcohol, white petrolatum, polyoxyl 40 stearate, propylene glycol, isopropyl myristate, and sorbitan monooleate with 0.3% methylparaben as a preservative.","molecularWeight":"","molecularFormula":""},"formularyStatus":[],"_enricherVersion":"v2","chemblMechanisms":[{"actionType":"INHIBITOR","targetChemblId":"CHEMBL2364668","mechanismComment":null,"mechanismOfAction":"Bacterial dihydropteroate synthase inhibitor"}],"developmentCodes":[],"ownershipHistory":[{"period":"1973-","companyName":"King Pharms","relationship":"Original Developer"},{"period":"present","companyName":"King Pharms Llc","relationship":"Current Owner"}],"pharmacokinetics":{"tmax":null,"halfLife":null,"linearPK":null,"clearance":null,"excretion":null,"metabolism":null,"proteinBinding":null,"bioavailability":null,"specialPopulations":{"age":null,"renal":null,"weight":null,"hepatic":null},"volumeOfDistribution":null},"publicationCount":1328,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"D06BA01","allCodes":["D06BA01","D06BA51"]},"biosimilarFilings":[],"faersTotalReports":2190,"originalDeveloper":"King Pharms","commercialAnalysis":{"text":"Silvadene, a topical antibiotic cream developed by Pfizer, is a marketed product used to treat burn wound infections, minor bacterial skin infections, and skin ulcers. According to MarketsandMarkets, the global topical drug delivery market is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$408.97 billion by the end of the period [1]. However, the market size for Silvadene specifically is not provided.\n\nThe competitive landscape for Silvadene is relatively stable, with Pfizer being a well-established player in the pharmaceutical industry. However, the market is threatened by generic competition and patent cliffs. IndustryARC forecasts that the Silver Sulfadiazine market will grow at a CAGR of 5.5% from 2026 to 2032, driven by innovations in formulations and enhanced treatment approaches [2]. Coherent Market Insights also reports that the Sulfonamides market, which includes Silver Sulfadiazine, will grow at a CAGR of 4.5% from 2026 to 2033, driven by the increasing prevalence of urinary tract infections and other bacterial infections [3].\n\nKey upcoming catalysts for Silvadene include potential label expansions and pipeline competitors. IndustryARC notes that Silver Sulfadiazine's role in combating antimicrobial resistance will drive market growth [2]. Additionally, Pfizer's pipeline may include new products that could compete with Silvadene or expand its indications.\n\nOverall, the market outlook for Silvadene is stable, driven by the growing demand for topical antibiotic creams and the increasing prevalence of bacterial infections. However, the market is threatened by generic competition and patent cliffs, and Pfizer must continue to innovate and expand its product portfolio to maintain its market position.\n\nReferences:\n[1] MarketsandMarkets, \"Topical Drug Delivery Market by Product (Formulation (Semi-solid, Emulsion), Transdermal Patch, Microneedle Patch, Drug-in-adhesive, Matrix Patch), Application (Dermal, Ophthalmic, Nasal, Vaginal, Rectal), End User, Region - Global Forecast to 2030\"\n[2] IndustryARC, \"Silver Sulfadiazine Market - Forecast(2026 - 2032)\"\n[3] Coherent Market Insights, \"Sulfonamides Market Size, Share and Forecast, 2025-2032\"","model":"llama-3.1-8b (Groq)","sources":[{"url":"https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.html","date":"","title":"Topical Drug Delivery Market Report 2025-2030, By ...","source":"www.marketsandmarkets.com"},{"url":"https://www.industryarc.com/Report/16242/silver-sulfadiazine-market-research","date":"","title":"Silver Sulfadiazine Market - Forecast(2026","source":"www.industryarc.com"},{"url":"https://www.coherentmarketinsights.com/industry-reports/sulfonamides-market","date":"","title":"Sulfonamides Market Size, Share and Forecast, 2025-2032","source":"www.coherentmarketinsights.com"}],"disclaimer":"AI-generated analysis based on public sources. Verify with primary sources for investment decisions.","generatedDate":"2026-04-07"},"faersReportsByYear":[{"time":"19981228","count":1},{"time":"20040122","count":2},{"time":"20040319","count":1},{"time":"20040325","count":1},{"time":"20040519","count":1},{"time":"20040602","count":1},{"time":"20040721","count":1},{"time":"20040722","count":1},{"time":"20040723","count":1},{"time":"20040729","count":1},{"time":"20040730","count":1},{"time":"20040913","count":1},{"time":"20040917","count":1},{"time":"20040920","count":1},{"time":"20040930","count":1},{"time":"20041021","count":1},{"time":"20041022","count":1},{"time":"20041101","count":1},{"time":"20041115","count":1},{"time":"20041116","count":1},{"time":"20050118","count":1},{"time":"20050121","count":1},{"time":"20050125","count":1},{"time":"20050201","count":1},{"time":"20050304","count":1},{"time":"20050316","count":1},{"time":"20050413","count":1},{"time":"20050415","count":1},{"time":"20050428","count":1},{"time":"20050720","count":2},{"time":"20050929","count":1},{"time":"20051020","count":2},{"time":"20051101","count":1},{"time":"20051123","count":1},{"time":"20051209","count":1},{"time":"20060112","count":1},{"time":"20060130","count":1},{"time":"20060210","count":1},{"time":"20060223","count":1},{"time":"20060413","count":1},{"time":"20060420","count":1},{"time":"20060714","count":1},{"time":"20060918","count":1},{"time":"20061003","count":1},{"time":"20061011","count":1},{"time":"20061019","count":1},{"time":"20061024","count":1},{"time":"20061129","count":1},{"time":"20061201","count":1},{"time":"20061221","count":1},{"time":"20070105","count":1},{"time":"20070108","count":1},{"time":"20070110","count":1},{"time":"20070112","count":2},{"time":"20070117","count":1},{"time":"20070118","count":1},{"time":"20070124","count":3},{"time":"20070126","count":1},{"time":"20070221","count":1},{"time":"20070419","count":1},{"time":"20070426","count":1},{"time":"20070503","count":1},{"time":"20070709","count":1},{"time":"20070724","count":1},{"time":"20070803","count":1},{"time":"20070827","count":1},{"time":"20070907","count":1},{"time":"20070927","count":1},{"time":"20071008","count":1},{"time":"20071017","count":1},{"time":"20071030","count":1},{"time":"20071102","count":1},{"time":"20071116","count":1},{"time":"20080331","count":2},{"time":"20080409","count":1},{"time":"20080430","count":1},{"time":"20080506","count":1},{"time":"20080508","count":1},{"time":"20080514","count":1},{"time":"20080520","count":1},{"time":"20080710","count":1},{"time":"20080807","count":1},{"time":"20080820","count":1},{"time":"20081009","count":1},{"time":"20081014","count":1},{"time":"20081023","count":1},{"time":"20081024","count":1},{"time":"20081030","count":1},{"time":"20081203","count":1},{"time":"20090224","count":1},{"time":"20090304","count":1},{"time":"20090310","count":1},{"time":"20090317","count":1},{"time":"20090318","count":2},{"time":"20090319","count":2},{"time":"20090320","count":2},{"time":"20090323","count":2},{"time":"20090402","count":1},{"time":"20090403","count":1},{"time":"20090409","count":1},{"time":"20090429","count":1},{"time":"20090518","count":1},{"time":"20090520","count":1},{"time":"20090611","count":1},{"time":"20090624","count":1},{"time":"20090709","count":1},{"time":"20090710","count":1},{"time":"20090717","count":1},{"time":"20090917","count":5},{"time":"20090922","count":1},{"time":"20090923","count":3},{"time":"20090925","count":1},{"time":"20091006","count":1},{"time":"20091024","count":1},{"time":"20091027","count":1},{"time":"20091104","count":1},{"time":"20091109","count":1},{"time":"20091130","count":1},{"time":"20091204","count":1},{"time":"20091208","count":1},{"time":"20091224","count":1},{"time":"20091231","count":1},{"time":"20100105","count":1},{"time":"20100108","count":1},{"time":"20100129","count":1},{"time":"20100204","count":2},{"time":"20100218","count":1},{"time":"20100315","count":1},{"time":"20100322","count":1},{"time":"20100407","count":1},{"time":"20100419","count":1},{"time":"20100427","count":1},{"time":"20100430","count":1},{"time":"20100503","count":1},{"time":"20100518","count":1},{"time":"20100521","count":1},{"time":"20100802","count":1},{"time":"20100830","count":1},{"time":"20100920","count":3},{"time":"20100927","count":1},{"time":"20100930","count":1},{"time":"20101011","count":1},{"time":"20101020","count":1},{"time":"20101101","count":1},{"time":"20101104","count":1},{"time":"20101110","count":1},{"time":"20101111","count":4},{"time":"20101116","count":2},{"time":"20101130","count":1},{"time":"20101202","count":1},{"time":"20101222","count":1},{"time":"20110121","count":1},{"time":"20110127","count":1},{"time":"20110201","count":1},{"time":"20110203","count":1},{"time":"20110316","count":1},{"time":"20110322","count":1},{"time":"20110323","count":1},{"time":"20110406","count":1},{"time":"20110412","count":1},{"time":"20110425","count":1},{"time":"20110511","count":1},{"time":"20110601","count":1},{"time":"20110614","count":1},{"time":"20110728","count":1},{"time":"20110803","count":1},{"time":"20110822","count":2},{"time":"20110902","count":1},{"time":"20110908","count":1},{"time":"20110926","count":1},{"time":"20110927","count":1},{"time":"20110928","count":1},{"time":"20111020","count":1},{"time":"20111103","count":1},{"time":"20111118","count":1},{"time":"20111121","count":1},{"time":"20111125","count":1},{"time":"20111130","count":1},{"time":"20111206","count":1},{"time":"20111207","count":1},{"time":"20111212","count":1},{"time":"20111219","count":2},{"time":"20111220","count":1},{"time":"20120105","count":1},{"time":"20120117","count":1},{"time":"20120123","count":1},{"time":"20120124","count":1},{"time":"20120128","count":1},{"time":"20120129","count":2},{"time":"20120207","count":1},{"time":"20120217","count":1},{"time":"20120222","count":1},{"time":"20120321","count":1},{"time":"20120322","count":1},{"time":"20120323","count":1},{"time":"20120327","count":1},{"time":"20120328","count":1},{"time":"20120416","count":2},{"time":"20120417","count":1},{"time":"20120418","count":1},{"time":"20120427","count":1},{"time":"20120430","count":2},{"time":"20120503","count":1},{"time":"20120508","count":1},{"time":"20120523","count":1},{"time":"20120524","count":1},{"time":"20120601","count":2},{"time":"20120605","count":3},{"time":"20120606","count":1},{"time":"20120607","count":1},{"time":"20120613","count":1},{"time":"20120621","count":1},{"time":"20120622","count":1},{"time":"20120625","count":2},{"time":"20120703","count":3},{"time":"20120713","count":1},{"time":"20120717","count":1},{"time":"20120723","count":1},{"time":"20120725","count":1},{"time":"20120726","count":1},{"time":"20120801","count":2},{"time":"20120807","count":2},{"time":"20120809","count":1},{"time":"20120813","count":1},{"time":"20120816","count":1},{"time":"20120823","count":1},{"time":"20120829","count":1},{"time":"20120831","count":1},{"time":"20120911","count":1},{"time":"20120913","count":1},{"time":"20120914","count":1},{"time":"20120920","count":2},{"time":"20120921","count":2},{"time":"20121001","count":2},{"time":"20121004","count":1},{"time":"20121005","count":1},{"time":"20121017","count":1},{"time":"20121023","count":1},{"time":"20121102","count":1},{"time":"20121109","count":1},{"time":"20121121","count":1},{"time":"20121126","count":1},{"time":"20121207","count":1},{"time":"20121214","count":1},{"time":"20121219","count":1},{"time":"20121220","count":1},{"time":"20121226","count":1},{"time":"20121227","count":1},{"time":"20130107","count":1},{"time":"20130117","count":1},{"time":"20130125","count":1},{"time":"20130128","count":1},{"time":"20130129","count":1},{"time":"20130131","count":1},{"time":"20130201","count":1},{"time":"20130215","count":1},{"time":"20130218","count":1},{"time":"20130219","count":1},{"time":"20130220","count":2},{"time":"20130311","count":1},{"time":"20130318","count":1},{"time":"20130328","count":1},{"time":"20130402","count":2},{"time":"20130418","count":1},{"time":"20130419","count":2},{"time":"20130422","count":1},{"time":"20130513","count":1},{"time":"20130610","count":1},{"time":"20130708","count":1},{"time":"20130711","count":1},{"time":"20130719","count":1},{"time":"20130722","count":1},{"time":"20130723","count":1},{"time":"20130906","count":1},{"time":"20130927","count":1},{"time":"20130930","count":1},{"time":"20131001","count":1},{"time":"20131007","count":1},{"time":"20131008","count":1},{"time":"20131009","count":1},{"time":"20131010","count":1},{"time":"20131025","count":1},{"time":"20131105","count":1},{"time":"20131108","count":1},{"time":"20131113","count":1},{"time":"20131121","count":1},{"time":"20131126","count":1},{"time":"20131202","count":2},{"time":"20131203","count":1},{"time":"20131210","count":1},{"time":"20131212","count":1},{"time":"20131219","count":1},{"time":"20131220","count":1},{"time":"20131225","count":1},{"time":"20140105","count":1},{"time":"20140107","count":1},{"time":"20140115","count":1},{"time":"20140129","count":2},{"time":"20140214","count":1},{"time":"20140219","count":1},{"time":"20140224","count":1},{"time":"20140225","count":1},{"time":"20140227","count":1},{"time":"20140303","count":2},{"time":"20140305","count":1},{"time":"20140312","count":1},{"time":"20140317","count":2},{"time":"20140324","count":1},{"time":"20140401","count":1},{"time":"20140407","count":1},{"time":"20140409","count":4},{"time":"20140410","count":1},{"time":"20140415","count":1},{"time":"20140417","count":1},{"time":"20140418","count":1},{"time":"20140509","count":1},{"time":"20140530","count":1},{"time":"20140616","count":1},{"time":"20140617","count":1},{"time":"20140620","count":1},{"time":"20140625","count":1},{"time":"20140701","count":1},{"time":"20140702","count":1},{"time":"20140707","count":1},{"time":"20140710","count":2},{"time":"20140814","count":1},{"time":"20140818","count":1},{"time":"20140822","count":2},{"time":"20140829","count":1},{"time":"20140902","count":1},{"time":"20140903","count":2},{"time":"20140923","count":1},{"time":"20140924","count":1},{"time":"20140929","count":1},{"time":"20141001","count":1},{"time":"20141006","count":1},{"time":"20141014","count":1},{"time":"20141024","count":1},{"time":"20141030","count":2},{"time":"20141031","count":1},{"time":"20141111","count":2},{"time":"20141114","count":1},{"time":"20141121","count":2},{"time":"20141215","count":2},{"time":"20141216","count":1},{"time":"20141217","count":2},{"time":"20141219","count":1},{"time":"20141229","count":1},{"time":"20150108","count":1},{"time":"20150109","count":2},{"time":"20150115","count":1},{"time":"20150120","count":1},{"time":"20150123","count":2},{"time":"20150126","count":2},{"time":"20150128","count":1},{"time":"20150130","count":1},{"time":"20150202","count":1},{"time":"20150206","count":1},{"time":"20150217","count":1},{"time":"20150218","count":1},{"time":"20150223","count":5},{"time":"20150225","count":2},{"time":"20150303","count":1},{"time":"20150310","count":1},{"time":"20150311","count":1},{"time":"20150317","count":2},{"time":"20150319","count":1},{"time":"20150324","count":1},{"time":"20150327","count":1},{"time":"20150330","count":1},{"time":"20150408","count":1},{"time":"20150410","count":1},{"time":"20150417","count":3},{"time":"20150427","count":2},{"time":"20150501","count":1},{"time":"20150505","count":1},{"time":"20150506","count":1},{"time":"20150508","count":3},{"time":"20150511","count":1},{"time":"20150526","count":1},{"time":"20150527","count":1},{"time":"20150603","count":1},{"time":"20150605","count":4},{"time":"20150608","count":1},{"time":"20150610","count":2},{"time":"20150619","count":1},{"time":"20150701","count":1},{"time":"20150706","count":1},{"time":"20150715","count":1},{"time":"20150721","count":1},{"time":"20150723","count":1},{"time":"20150724","count":1},{"time":"20150728","count":1},{"time":"20150731","count":2},{"time":"20150803","count":1},{"time":"20150804","count":1},{"time":"20150805","count":1},{"time":"20150821","count":1},{"time":"20150904","count":2},{"time":"20150923","count":3},{"time":"20150929","count":1},{"time":"20151009","count":2},{"time":"20151013","count":1},{"time":"20151023","count":1},{"time":"20151104","count":1},{"time":"20151111","count":1},{"time":"20151112","count":1},{"time":"20151116","count":1},{"time":"20151118","count":1},{"time":"20151127","count":1},{"time":"20151203","count":1},{"time":"20151207","count":1},{"time":"20151210","count":2},{"time":"20151211","count":1},{"time":"20151215","count":1},{"time":"20151216","count":1},{"time":"20151222","count":2},{"time":"20151228","count":2},{"time":"20151229","count":2},{"time":"20160105","count":1},{"time":"20160111","count":2},{"time":"20160112","count":1},{"time":"20160115","count":1},{"time":"20160118","count":1},{"time":"20160120","count":1},{"time":"20160125","count":1},{"time":"20160126","count":1},{"time":"20160128","count":3},{"time":"20160129","count":1},{"time":"20160201","count":1},{"time":"20160202","count":2},{"time":"20160204","count":3},{"time":"20160210","count":1},{"time":"20160211","count":1},{"time":"20160215","count":1},{"time":"20160217","count":1},{"time":"20160218","count":1},{"time":"20160221","count":1},{"time":"20160222","count":2},{"time":"20160223","count":1},{"time":"20160301","count":1},{"time":"20160303","count":1},{"time":"20160309","count":1},{"time":"20160314","count":1},{"time":"20160323","count":1},{"time":"20160325","count":2},{"time":"20160328","count":2},{"time":"20160329","count":1},{"time":"20160330","count":3},{"time":"20160401","count":1},{"time":"20160405","count":1},{"time":"20160406","count":2},{"time":"20160408","count":2},{"time":"20160412","count":9},{"time":"20160418","count":1},{"time":"20160420","count":1},{"time":"20160422","count":1},{"time":"20160427","count":2},{"time":"20160428","count":2},{"time":"20160503","count":1},{"time":"20160506","count":1},{"time":"20160509","count":1},{"time":"20160510","count":2},{"time":"20160511","count":1},{"time":"20160513","count":3},{"time":"20160517","count":1},{"time":"20160518","count":1},{"time":"20160520","count":1},{"time":"20160523","count":1},{"time":"20160524","count":1},{"time":"20160526","count":1},{"time":"20160527","count":2},{"time":"20160530","count":1},{"time":"20160601","count":1},{"time":"20160602","count":1},{"time":"20160603","count":2},{"time":"20160609","count":3},{"time":"20160613","count":3},{"time":"20160621","count":2},{"time":"20160622","count":3},{"time":"20160624","count":1},{"time":"20160628","count":1},{"time":"20160630","count":1},{"time":"20160705","count":1},{"time":"20160707","count":3},{"time":"20160708","count":1},{"time":"20160711","count":1},{"time":"20160714","count":1},{"time":"20160719","count":1},{"time":"20160721","count":1},{"time":"20160725","count":1},{"time":"20160726","count":3},{"time":"20160728","count":3},{"time":"20160729","count":1},{"time":"20160802","count":1},{"time":"20160804","count":1},{"time":"20160805","count":2},{"time":"20160808","count":7},{"time":"20160809","count":1},{"time":"20160812","count":2},{"time":"20160818","count":2},{"time":"20160819","count":1},{"time":"20160822","count":2},{"time":"20160823","count":2},{"time":"20160825","count":1},{"time":"20160831","count":2},{"time":"20160901","count":5},{"time":"20160902","count":1},{"time":"20160906","count":1},{"time":"20160907","count":1},{"time":"20160914","count":1},{"time":"20160915","count":2},{"time":"20160916","count":1},{"time":"20160919","count":1},{"time":"20160920","count":2},{"time":"20160928","count":1},{"time":"20160929","count":2},{"time":"20161004","count":2},{"time":"20161005","count":2},{"time":"20161006","count":1},{"time":"20161010","count":1},{"time":"20161012","count":1},{"time":"20161019","count":2},{"time":"20161021","count":3},{"time":"20161025","count":2},{"time":"20161027","count":3},{"time":"20161028","count":1},{"time":"20161102","count":1},{"time":"20161104","count":1},{"time":"20161108","count":2},{"time":"20161110","count":2},{"time":"20161114","count":1},{"time":"20161115","count":2},{"time":"20161118","count":1},{"time":"20161123","count":2},{"time":"20161128","count":1},{"time":"20161202","count":1},{"time":"20161209","count":1},{"time":"20161212","count":1},{"time":"20161214","count":2},{"time":"20161215","count":2},{"time":"20161219","count":2},{"time":"20161226","count":1},{"time":"20161229","count":1},{"time":"20170109","count":2},{"time":"20170110","count":3},{"time":"20170111","count":1},{"time":"20170127","count":1},{"time":"20170131","count":2},{"time":"20170201","count":1},{"time":"20170202","count":3},{"time":"20170208","count":2},{"time":"20170209","count":1},{"time":"20170210","count":1},{"time":"20170213","count":1},{"time":"20170216","count":2},{"time":"20170217","count":1},{"time":"20170224","count":1},{"time":"20170227","count":1},{"time":"20170228","count":2},{"time":"20170302","count":2},{"time":"20170306","count":1},{"time":"20170307","count":1},{"time":"20170309","count":1},{"time":"20170310","count":1},{"time":"20170313","count":1},{"time":"20170314","count":2},{"time":"20170322","count":1},{"time":"20170329","count":1},{"time":"20170331","count":1},{"time":"20170404","count":1},{"time":"20170407","count":1},{"time":"20170411","count":1},{"time":"20170412","count":1},{"time":"20170413","count":2},{"time":"20170420","count":8},{"time":"20170425","count":1},{"time":"20170501","count":1},{"time":"20170502","count":1},{"time":"20170508","count":1},{"time":"20170509","count":1},{"time":"20170511","count":1},{"time":"20170516","count":3},{"time":"20170519","count":1},{"time":"20170524","count":2},{"time":"20170525","count":1},{"time":"20170531","count":3},{"time":"20170602","count":1},{"time":"20170608","count":1},{"time":"20170614","count":1},{"time":"20170621","count":3},{"time":"20170622","count":1},{"time":"20170626","count":1},{"time":"20170628","count":1},{"time":"20170629","count":1},{"time":"20170630","count":2},{"time":"20170705","count":2},{"time":"20170706","count":2},{"time":"20170707","count":1},{"time":"20170711","count":1},{"time":"20170714","count":1},{"time":"20170717","count":1},{"time":"20170718","count":1},{"time":"20170721","count":1},{"time":"20170724","count":1},{"time":"20170725","count":1},{"time":"20170727","count":2},{"time":"20170728","count":1},{"time":"20170731","count":1},{"time":"20170802","count":2},{"time":"20170807","count":2},{"time":"20170809","count":2},{"time":"20170810","count":2},{"time":"20170811","count":1},{"time":"20170814","count":1},{"time":"20170817","count":2},{"time":"20170822","count":2},{"time":"20170829","count":1},{"time":"20170904","count":3},{"time":"20170906","count":1},{"time":"20170907","count":1},{"time":"20170908","count":2},{"time":"20170914","count":1},{"time":"20170918","count":1},{"time":"20171005","count":1},{"time":"20171006","count":1},{"time":"20171010","count":1},{"time":"20171012","count":1},{"time":"20171015","count":1},{"time":"20171017","count":1},{"time":"20171025","count":2},{"time":"20171027","count":2},{"time":"20171030","count":2},{"time":"20171107","count":1},{"time":"20171109","count":1},{"time":"20171114","count":2},{"time":"20171120","count":1},{"time":"20171121","count":1},{"time":"20171122","count":1},{"time":"20171123","count":1},{"time":"20171128","count":3},{"time":"20171201","count":2},{"time":"20171205","count":1},{"time":"20171207","count":1},{"time":"20171211","count":3},{"time":"20171214","count":1},{"time":"20171215","count":1},{"time":"20171218","count":1},{"time":"20171220","count":1},{"time":"20171225","count":1},{"time":"20171227","count":1},{"time":"20180103","count":1},{"time":"20180104","count":1},{"time":"20180108","count":2},{"time":"20180109","count":2},{"time":"20180111","count":1},{"time":"20180115","count":2},{"time":"20180116","count":1},{"time":"20180117","count":1},{"time":"20180118","count":1},{"time":"20180122","count":1},{"time":"20180124","count":1},{"time":"20180125","count":1},{"time":"20180126","count":1},{"time":"20180127","count":1},{"time":"20180201","count":3},{"time":"20180202","count":1},{"time":"20180210","count":1},{"time":"20180212","count":1},{"time":"20180214","count":1},{"time":"20180216","count":1},{"time":"20180220","count":1},{"time":"20180221","count":1},{"time":"20180226","count":3},{"time":"20180228","count":1},{"time":"20180301","count":1},{"time":"20180305","count":1},{"time":"20180307","count":1},{"time":"20180308","count":1},{"time":"20180312","count":1},{"time":"20180322","count":2},{"time":"20180323","count":1},{"time":"20180326","count":2},{"time":"20180327","count":1},{"time":"20180328","count":3},{"time":"20180330","count":1},{"time":"20180403","count":3},{"time":"20180405","count":1},{"time":"20180406","count":1},{"time":"20180408","count":1},{"time":"20180409","count":1},{"time":"20180410","count":1},{"time":"20180413","count":2},{"time":"20180414","count":1},{"time":"20180417","count":1},{"time":"20180418","count":1},{"time":"20180420","count":1},{"time":"20180423","count":1},{"time":"20180424","count":3},{"time":"20180425","count":1},{"time":"20180427","count":1},{"time":"20180430","count":5},{"time":"20180501","count":1},{"time":"20180504","count":1},{"time":"20180507","count":1},{"time":"20180508","count":3},{"time":"20180509","count":1},{"time":"20180514","count":1},{"time":"20180518","count":2},{"time":"20180521","count":2},{"time":"20180523","count":1},{"time":"20180524","count":2},{"time":"20180528","count":1},{"time":"20180530","count":1},{"time":"20180531","count":2},{"time":"20180612","count":2},{"time":"20180619","count":1},{"time":"20180625","count":1},{"time":"20180627","count":1},{"time":"20180628","count":1},{"time":"20180703","count":1},{"time":"20180709","count":2},{"time":"20180711","count":1},{"time":"20180713","count":3},{"time":"20180716","count":1},{"time":"20180718","count":1},{"time":"20180720","count":2},{"time":"20180725","count":1},{"time":"20180726","count":2},{"time":"20180727","count":1},{"time":"20180729","count":1},{"time":"20180731","count":3},{"time":"20180801","count":2},{"time":"20180802","count":3},{"time":"20180806","count":1},{"time":"20180813","count":1},{"time":"20180814","count":2},{"time":"20180817","count":1},{"time":"20180820","count":2},{"time":"20180822","count":1},{"time":"20180824","count":2},{"time":"20180829","count":1},{"time":"20180905","count":2},{"time":"20180911","count":1},{"time":"20180918","count":1},{"time":"20180920","count":1},{"time":"20180924","count":2},{"time":"20180925","count":4},{"time":"20180930","count":1},{"time":"20181002","count":1},{"time":"20181004","count":1},{"time":"20181008","count":1},{"time":"20181009","count":1},{"time":"20181011","count":2},{"time":"20181017","count":1},{"time":"20181022","count":1},{"time":"20181023","count":1},{"time":"20181026","count":1},{"time":"20181030","count":1},{"time":"20181102","count":1},{"time":"20181107","count":1},{"time":"20181109","count":2},{"time":"20181112","count":1},{"time":"20181113","count":2},{"time":"20181114","count":3},{"time":"20181116","count":2},{"time":"20181119","count":1},{"time":"20181120","count":2},{"time":"20181122","count":1},{"time":"20181126","count":1},{"time":"20181127","count":1},{"time":"20181129","count":1},{"time":"20181204","count":1},{"time":"20181205","count":1},{"time":"20181206","count":1},{"time":"20181210","count":1},{"time":"20181213","count":1},{"time":"20181219","count":1},{"time":"20181228","count":2},{"time":"20181231","count":1},{"time":"20190103","count":1},{"time":"20190104","count":1},{"time":"20190107","count":1},{"time":"20190109","count":1},{"time":"20190118","count":1},{"time":"20190124","count":1},{"time":"20190125","count":1},{"time":"20190130","count":5},{"time":"20190131","count":1},{"time":"20190201","count":1},{"time":"20190208","count":3},{"time":"20190212","count":1},{"time":"20190215","count":2},{"time":"20190218","count":1},{"time":"20190219","count":4},{"time":"20190220","count":2},{"time":"20190222","count":1},{"time":"20190227","count":1},{"time":"20190301","count":1},{"time":"20190304","count":1},{"time":"20190305","count":1},{"time":"20190306","count":2},{"time":"20190307","count":1},{"time":"20190308","count":1},{"time":"20190309","count":1},{"time":"20190311","count":1},{"time":"20190313","count":1},{"time":"20190318","count":2},{"time":"20190319","count":1},{"time":"20190325","count":1},{"time":"20190326","count":1},{"time":"20190328","count":1},{"time":"20190329","count":1},{"time":"20190401","count":2},{"time":"20190402","count":2},{"time":"20190404","count":1},{"time":"20190412","count":1},{"time":"20190417","count":1},{"time":"20190419","count":1},{"time":"20190422","count":1},{"time":"20190423","count":4},{"time":"20190425","count":2},{"time":"20190426","count":2},{"time":"20190429","count":1},{"time":"20190430","count":3},{"time":"20190506","count":4},{"time":"20190507","count":3},{"time":"20190510","count":1},{"time":"20190513","count":4},{"time":"20190515","count":1},{"time":"20190517","count":1},{"time":"20190520","count":1},{"time":"20190528","count":2},{"time":"20190607","count":1},{"time":"20190611","count":1},{"time":"20190614","count":1},{"time":"20190619","count":4},{"time":"20190621","count":2},{"time":"20190624","count":1},{"time":"20190625","count":2},{"time":"20190626","count":1},{"time":"20190701","count":1},{"time":"20190702","count":1},{"time":"20190705","count":3},{"time":"20190708","count":1},{"time":"20190715","count":1},{"time":"20190718","count":1},{"time":"20190722","count":2},{"time":"20190725","count":2},{"time":"20190726","count":1},{"time":"20190730","count":2},{"time":"20190731","count":2},{"time":"20190807","count":1},{"time":"20190811","count":1},{"time":"20190814","count":1},{"time":"20190821","count":1},{"time":"20190828","count":1},{"time":"20190829","count":2},{"time":"20190903","count":1},{"time":"20190906","count":3},{"time":"20190909","count":1},{"time":"20190911","count":1},{"time":"20190912","count":1},{"time":"20190917","count":4},{"time":"20190918","count":2},{"time":"20190920","count":1},{"time":"20190923","count":2},{"time":"20190924","count":2},{"time":"20190926","count":2},{"time":"20191004","count":2},{"time":"20191010","count":2},{"time":"20191015","count":2},{"time":"20191016","count":1},{"time":"20191018","count":1},{"time":"20191021","count":2},{"time":"20191023","count":1},{"time":"20191025","count":2},{"time":"20191030","count":1},{"time":"20191031","count":1},{"time":"20191105","count":1},{"time":"20191106","count":1},{"time":"20191108","count":1},{"time":"20191112","count":2},{"time":"20191113","count":1},{"time":"20191114","count":2},{"time":"20191119","count":1},{"time":"20191120","count":1},{"time":"20191121","count":2},{"time":"20191125","count":1},{"time":"20191126","count":1},{"time":"20191127","count":3},{"time":"20191205","count":2},{"time":"20191211","count":2},{"time":"20191212","count":1},{"time":"20191213","count":1},{"time":"20191216","count":1},{"time":"20191226","count":2},{"time":"20191227","count":2},{"time":"20191228","count":1},{"time":"20191230","count":1},{"time":"20191231","count":2},{"time":"20200101","count":1},{"time":"20200107","count":2},{"time":"20200108","count":1},{"time":"20200109","count":1},{"time":"20200113","count":1},{"time":"20200117","count":1},{"time":"20200124","count":1},{"time":"20200203","count":1},{"time":"20200204","count":1},{"time":"20200205","count":1},{"time":"20200211","count":3},{"time":"20200212","count":1},{"time":"20200214","count":3},{"time":"20200217","count":1},{"time":"20200218","count":2},{"time":"20200219","count":6},{"time":"20200221","count":2},{"time":"20200224","count":1},{"time":"20200225","count":2},{"time":"20200304","count":3},{"time":"20200307","count":1},{"time":"20200313","count":2},{"time":"20200317","count":1},{"time":"20200319","count":1},{"time":"20200323","count":1},{"time":"20200324","count":1},{"time":"20200327","count":1},{"time":"20200402","count":2},{"time":"20200407","count":1},{"time":"20200408","count":3},{"time":"20200411","count":1},{"time":"20200413","count":2},{"time":"20200415","count":1},{"time":"20200416","count":1},{"time":"20200420","count":2},{"time":"20200424","count":1},{"time":"20200501","count":2},{"time":"20200505","count":1},{"time":"20200511","count":1},{"time":"20200512","count":1},{"time":"20200513","count":2},{"time":"20200514","count":1},{"time":"20200515","count":2},{"time":"20200519","count":1},{"time":"20200520","count":1},{"time":"20200521","count":1},{"time":"20200522","count":1},{"time":"20200526","count":2},{"time":"20200527","count":1},{"time":"20200531","count":1},{"time":"20200601","count":1},{"time":"20200602","count":1},{"time":"20200603","count":1},{"time":"20200604","count":1},{"time":"20200609","count":1},{"time":"20200610","count":1},{"time":"20200615","count":2},{"time":"20200618","count":1},{"time":"20200619","count":1},{"time":"20200620","count":1},{"time":"20200623","count":3},{"time":"20200629","count":2},{"time":"20200701","count":1},{"time":"20200702","count":2},{"time":"20200706","count":1},{"time":"20200707","count":2},{"time":"20200708","count":3},{"time":"20200709","count":1},{"time":"20200710","count":2},{"time":"20200713","count":2},{"time":"20200715","count":1},{"time":"20200717","count":1},{"time":"20200721","count":1},{"time":"20200724","count":1},{"time":"20200726","count":1},{"time":"20200727","count":1},{"time":"20200729","count":1},{"time":"20200731","count":1},{"time":"20200801","count":1},{"time":"20200805","count":1},{"time":"20200806","count":1},{"time":"20200807","count":1},{"time":"20200813","count":1},{"time":"20200814","count":1},{"time":"20200817","count":1},{"time":"20200819","count":1},{"time":"20200820","count":2},{"time":"20200821","count":1},{"time":"20200825","count":1},{"time":"20200826","count":3},{"time":"20200827","count":1},{"time":"20200828","count":2},{"time":"20200908","count":1},{"time":"20200911","count":2},{"time":"20200912","count":1},{"time":"20200915","count":1},{"time":"20200921","count":1},{"time":"20200923","count":1},{"time":"20200924","count":2},{"time":"20200928","count":1},{"time":"20200929","count":3},{"time":"20200930","count":4},{"time":"20201002","count":1},{"time":"20201004","count":1},{"time":"20201005","count":1},{"time":"20201008","count":1},{"time":"20201012","count":2},{"time":"20201013","count":1},{"time":"20201015","count":1},{"time":"20201016","count":2},{"time":"20201019","count":2},{"time":"20201020","count":1},{"time":"20201021","count":2},{"time":"20201024","count":1},{"time":"20201028","count":1},{"time":"20201029","count":1},{"time":"20201031","count":1},{"time":"20201101","count":1},{"time":"20201102","count":2},{"time":"20201103","count":1},{"time":"20201108","count":1},{"time":"20201110","count":3},{"time":"20201114","count":1},{"time":"20201117","count":2},{"time":"20201123","count":1},{"time":"20201201","count":1},{"time":"20201203","count":1},{"time":"20201204","count":1},{"time":"20201208","count":1},{"time":"20201209","count":1},{"time":"20201210","count":1},{"time":"20201214","count":1},{"time":"20201215","count":1},{"time":"20201218","count":1},{"time":"20201221","count":1},{"time":"20201222","count":3},{"time":"20201223","count":1},{"time":"20201230","count":1},{"time":"20201231","count":1},{"time":"20210104","count":1},{"time":"20210105","count":1},{"time":"20210108","count":1},{"time":"20210111","count":1},{"time":"20210113","count":1},{"time":"20210120","count":2},{"time":"20210125","count":1},{"time":"20210126","count":2},{"time":"20210128","count":1},{"time":"20210129","count":1},{"time":"20210203","count":4},{"time":"20210205","count":1},{"time":"20210209","count":1},{"time":"20210210","count":1},{"time":"20210211","count":3},{"time":"20210215","count":1},{"time":"20210216","count":1},{"time":"20210217","count":1},{"time":"20210218","count":8},{"time":"20210219","count":46},{"time":"20210220","count":1},{"time":"20210222","count":2},{"time":"20210224","count":1},{"time":"20210301","count":1},{"time":"20210302","count":1},{"time":"20210303","count":2},{"time":"20210304","count":1},{"time":"20210305","count":1},{"time":"20210309","count":1},{"time":"20210310","count":2},{"time":"20210311","count":1},{"time":"20210312","count":1},{"time":"20210315","count":1},{"time":"20210318","count":1},{"time":"20210319","count":1},{"time":"20210324","count":1},{"time":"20210329","count":1},{"time":"20210330","count":1},{"time":"20210331","count":3},{"time":"20210402","count":2},{"time":"20210405","count":1},{"time":"20210406","count":1},{"time":"20210408","count":1},{"time":"20210409","count":1},{"time":"20210412","count":1},{"time":"20210414","count":1},{"time":"20210421","count":1},{"time":"20210426","count":1},{"time":"20210427","count":1},{"time":"20210506","count":1},{"time":"20210511","count":2},{"time":"20210514","count":1},{"time":"20210519","count":1},{"time":"20210523","count":1},{"time":"20210525","count":1},{"time":"20210528","count":1},{"time":"20210603","count":1},{"time":"20210608","count":1},{"time":"20210609","count":3},{"time":"20210610","count":1},{"time":"20210616","count":1},{"time":"20210617","count":1},{"time":"20210618","count":1},{"time":"20210622","count":1},{"time":"20210624","count":1},{"time":"20210625","count":1},{"time":"20210702","count":1},{"time":"20210706","count":1},{"time":"20210707","count":2},{"time":"20210709","count":1},{"time":"20210715","count":1},{"time":"20210720","count":1},{"time":"20210721","count":1},{"time":"20210722","count":2},{"time":"20210723","count":1},{"time":"20210724","count":1},{"time":"20210726","count":1},{"time":"20210728","count":3},{"time":"20210729","count":1},{"time":"20210803","count":1},{"time":"20210804","count":2},{"time":"20210805","count":1},{"time":"20210817","count":1},{"time":"20210824","count":1},{"time":"20210825","count":3},{"time":"20210828","count":2},{"time":"20210830","count":1},{"time":"20210831","count":1},{"time":"20210903","count":1},{"time":"20210908","count":1},{"time":"20210913","count":2},{"time":"20210915","count":1},{"time":"20210920","count":3},{"time":"20210921","count":1},{"time":"20210924","count":1},{"time":"20210926","count":1},{"time":"20210930","count":1},{"time":"20211005","count":1},{"time":"20211006","count":1},{"time":"20211008","count":1},{"time":"20211015","count":1},{"time":"20211018","count":2},{"time":"20211019","count":1},{"time":"20211102","count":1},{"time":"20211105","count":1},{"time":"20211108","count":1},{"time":"20211117","count":1},{"time":"20211118","count":1},{"time":"20211119","count":1},{"time":"20211122","count":1},{"time":"20211124","count":2},{"time":"20211129","count":1},{"time":"20211205","count":1},{"time":"20211211","count":1},{"time":"20211212","count":1},{"time":"20211214","count":1},{"time":"20211215","count":1},{"time":"20211218","count":1},{"time":"20211220","count":2},{"time":"20211221","count":1},{"time":"20211225","count":2},{"time":"20211230","count":1},{"time":"20220110","count":1},{"time":"20220114","count":1},{"time":"20220120","count":1},{"time":"20220124","count":1},{"time":"20220125","count":1},{"time":"20220131","count":1},{"time":"20220201","count":1},{"time":"20220202","count":1},{"time":"20220208","count":1},{"time":"20220210","count":1},{"time":"20220211","count":1},{"time":"20220215","count":1},{"time":"20220216","count":1},{"time":"20220217","count":38},{"time":"20220218","count":2},{"time":"20220221","count":1},{"time":"20220222","count":1},{"time":"20220227","count":1},{"time":"20220228","count":1},{"time":"20220307","count":3},{"time":"20220309","count":1},{"time":"20220310","count":1},{"time":"20220319","count":1},{"time":"20220321","count":1},{"time":"20220328","count":1},{"time":"20220329","count":1},{"time":"20220331","count":2},{"time":"20220404","count":2},{"time":"20220407","count":1},{"time":"20220409","count":1},{"time":"20220425","count":1},{"time":"20220503","count":1},{"time":"20220504","count":1},{"time":"20220505","count":1},{"time":"20220506","count":1},{"time":"20220507","count":1},{"time":"20220509","count":2},{"time":"20220510","count":3},{"time":"20220512","count":2},{"time":"20220513","count":2},{"time":"20220519","count":2},{"time":"20220523","count":1},{"time":"20220524","count":1},{"time":"20220525","count":1},{"time":"20220527","count":1},{"time":"20220528","count":1},{"time":"20220530","count":2},{"time":"20220602","count":2},{"time":"20220604","count":1},{"time":"20220605","count":1},{"time":"20220609","count":1},{"time":"20220616","count":1},{"time":"20220617","count":1},{"time":"20220620","count":1},{"time":"20220621","count":1},{"time":"20220624","count":2},{"time":"20220705","count":1},{"time":"20220706","count":1},{"time":"20220707","count":1},{"time":"20220713","count":2},{"time":"20220715","count":1},{"time":"20220720","count":1},{"time":"20220726","count":1},{"time":"20220728","count":2},{"time":"20220729","count":1},{"time":"20220730","count":1},{"time":"20220803","count":1},{"time":"20220804","count":1},{"time":"20220805","count":1},{"time":"20220811","count":1},{"time":"20220813","count":1},{"time":"20220814","count":1},{"time":"20220818","count":1},{"time":"20220822","count":1},{"time":"20220823","count":2},{"time":"20220831","count":1},{"time":"20220906","count":1},{"time":"20220908","count":1},{"time":"20220909","count":1},{"time":"20220911","count":1},{"time":"20220913","count":2},{"time":"20220915","count":4},{"time":"20220916","count":1},{"time":"20220917","count":1},{"time":"20220927","count":1},{"time":"20220928","count":2},{"time":"20220930","count":1},{"time":"20221004","count":1},{"time":"20221005","count":1},{"time":"20221007","count":1},{"time":"20221013","count":1},{"time":"20221017","count":1},{"time":"20221019","count":1},{"time":"20221021","count":1},{"time":"20221026","count":2},{"time":"20221030","count":1},{"time":"20221031","count":1},{"time":"20221101","count":1},{"time":"20221104","count":1},{"time":"20221108","count":1},{"time":"20221109","count":1},{"time":"20221110","count":1},{"time":"20221114","count":1},{"time":"20221115","count":1},{"time":"20221118","count":1},{"time":"20221123","count":1},{"time":"20221201","count":1},{"time":"20221209","count":1},{"time":"20221215","count":1},{"time":"20221216","count":2},{"time":"20221218","count":1},{"time":"20221220","count":2},{"time":"20221221","count":1},{"time":"20221230","count":2},{"time":"20230101","count":1},{"time":"20230103","count":1},{"time":"20230113","count":1},{"time":"20230117","count":1},{"time":"20230124","count":1},{"time":"20230131","count":1},{"time":"20230201","count":4},{"time":"20230202","count":1},{"time":"20230206","count":1},{"time":"20230207","count":2},{"time":"20230210","count":1},{"time":"20230217","count":24},{"time":"20230220","count":1},{"time":"20230221","count":1},{"time":"20230222","count":1},{"time":"20230227","count":2},{"time":"20230301","count":1},{"time":"20230305","count":1},{"time":"20230308","count":1},{"time":"20230309","count":1},{"time":"20230316","count":1},{"time":"20230317","count":2},{"time":"20230321","count":1},{"time":"20230324","count":1},{"time":"20230325","count":1},{"time":"20230327","count":1},{"time":"20230329","count":1},{"time":"20230405","count":2},{"time":"20230410","count":2},{"time":"20230411","count":1},{"time":"20230413","count":2},{"time":"20230418","count":2},{"time":"20230421","count":1},{"time":"20230424","count":2},{"time":"20230425","count":1},{"time":"20230426","count":1},{"time":"20230427","count":1},{"time":"20230428","count":1},{"time":"20230501","count":1},{"time":"20230507","count":1},{"time":"20230508","count":1},{"time":"20230509","count":1},{"time":"20230510","count":1},{"time":"20230511","count":1},{"time":"20230513","count":1},{"time":"20230516","count":2},{"time":"20230517","count":2},{"time":"20230518","count":1},{"time":"20230519","count":1},{"time":"20230522","count":2},{"time":"20230523","count":1},{"time":"20230524","count":1},{"time":"20230528","count":1},{"time":"20230529","count":1},{"time":"20230531","count":1},{"time":"20230606","count":1},{"time":"20230607","count":1},{"time":"20230612","count":2},{"time":"20230614","count":1},{"time":"20230615","count":1},{"time":"20230616","count":1},{"time":"20230619","count":3},{"time":"20230620","count":1},{"time":"20230629","count":2},{"time":"20230704","count":1},{"time":"20230707","count":1},{"time":"20230712","count":1},{"time":"20230713","count":1},{"time":"20230718","count":1},{"time":"20230727","count":1},{"time":"20230728","count":1},{"time":"20230731","count":1},{"time":"20230801","count":1},{"time":"20230803","count":1},{"time":"20230804","count":1},{"time":"20230809","count":1},{"time":"20230810","count":1},{"time":"20230815","count":1},{"time":"20230818","count":1},{"time":"20230823","count":4},{"time":"20230829","count":1},{"time":"20230907","count":1},{"time":"20230908","count":1},{"time":"20230920","count":1},{"time":"20230927","count":1},{"time":"20231005","count":1},{"time":"20231010","count":1},{"time":"20231011","count":1},{"time":"20231012","count":1},{"time":"20231013","count":1},{"time":"20231017","count":1},{"time":"20231019","count":1},{"time":"20231020","count":1},{"time":"20231024","count":1},{"time":"20231025","count":2},{"time":"20231027","count":1},{"time":"20231106","count":2},{"time":"20231108","count":1},{"time":"20231109","count":1},{"time":"20231110","count":1},{"time":"20231114","count":1},{"time":"20231115","count":1},{"time":"20231120","count":1},{"time":"20231121","count":1},{"time":"20231123","count":1},{"time":"20231130","count":1},{"time":"20231209","count":1},{"time":"20231211","count":2},{"time":"20231213","count":1},{"time":"20231219","count":1},{"time":"20231222","count":1},{"time":"20231226","count":1},{"time":"20231227","count":1},{"time":"20231228","count":1},{"time":"20240104","count":1},{"time":"20240106","count":1},{"time":"20240110","count":1},{"time":"20240112","count":2},{"time":"20240116","count":1},{"time":"20240122","count":1},{"time":"20240124","count":1},{"time":"20240204","count":2},{"time":"20240207","count":2},{"time":"20240208","count":1},{"time":"20240209","count":1},{"time":"20240215","count":1},{"time":"20240216","count":10},{"time":"20240219","count":1},{"time":"20240226","count":1},{"time":"20240227","count":2},{"time":"20240228","count":1},{"time":"20240306","count":1},{"time":"20240308","count":1},{"time":"20240311","count":1},{"time":"20240320","count":1},{"time":"20240325","count":1},{"time":"20240404","count":2},{"time":"20240418","count":1},{"time":"20240423","count":1},{"time":"20240424","count":1},{"time":"20240425","count":1},{"time":"20240430","count":1},{"time":"20240507","count":1},{"time":"20240510","count":1},{"time":"20240512","count":1},{"time":"20240515","count":2},{"time":"20240517","count":2},{"time":"20240518","count":1},{"time":"20240520","count":1},{"time":"20240522","count":1},{"time":"20240524","count":1},{"time":"20240531","count":1},{"time":"20240610","count":1},{"time":"20240619","count":2},{"time":"20240620","count":1},{"time":"20240627","count":1},{"time":"20240701","count":1},{"time":"20240703","count":2},{"time":"20240705","count":1},{"time":"20240708","count":1},{"time":"20240711","count":2},{"time":"20240718","count":1},{"time":"20240723","count":1},{"time":"20240731","count":1},{"time":"20240802","count":1},{"time":"20240808","count":1},{"time":"20240809","count":1},{"time":"20240812","count":2},{"time":"20240813","count":1},{"time":"20240814","count":2},{"time":"20240820","count":1},{"time":"20240821","count":2},{"time":"20240826","count":1},{"time":"20240827","count":1},{"time":"20240828","count":2},{"time":"20240902","count":2},{"time":"20240906","count":2},{"time":"20240911","count":4},{"time":"20240914","count":1},{"time":"20240917","count":1},{"time":"20240924","count":1},{"time":"20240926","count":1},{"time":"20241007","count":1},{"time":"20241010","count":1},{"time":"20241017","count":2},{"time":"20241021","count":1},{"time":"20241023","count":1},{"time":"20241024","count":1},{"time":"20241030","count":1},{"time":"20241105","count":1},{"time":"20241106","count":1},{"time":"20241111","count":1},{"time":"20241112","count":1},{"time":"20241119","count":1},{"time":"20241125","count":1},{"time":"20241129","count":1},{"time":"20241205","count":1},{"time":"20241213","count":1},{"time":"20241216","count":1},{"time":"20241217","count":1},{"time":"20241218","count":2},{"time":"20241219","count":1},{"time":"20250113","count":1},{"time":"20250118","count":1},{"time":"20250123","count":2},{"time":"20250124","count":1},{"time":"20250128","count":1},{"time":"20250129","count":2},{"time":"20250202","count":8},{"time":"20250204","count":1},{"time":"20250205","count":1},{"time":"20250206","count":1},{"time":"20250208","count":1},{"time":"20250222","count":1},{"time":"20250225","count":1},{"time":"20250303","count":1},{"time":"20250305","count":1},{"time":"20250306","count":1},{"time":"20250310","count":1},{"time":"20250311","count":1},{"time":"20250320","count":3},{"time":"20250321","count":1},{"time":"20250326","count":1},{"time":"20250328","count":3},{"time":"20250329","count":1},{"time":"20250401","count":2},{"time":"20250402","count":1},{"time":"20250407","count":1},{"time":"20250415","count":2},{"time":"20250418","count":1},{"time":"20250422","count":1},{"time":"20250429","count":1},{"time":"20250511","count":1},{"time":"20250522","count":1},{"time":"20250626","count":1},{"time":"20250628","count":1},{"time":"20250701","count":1},{"time":"20250703","count":1},{"time":"20250709","count":1},{"time":"20250716","count":1},{"time":"20250717","count":1},{"time":"20250725","count":2},{"time":"20250728","count":1},{"time":"20250729","count":1},{"time":"20250801","count":2},{"time":"20250804","count":1},{"time":"20250806","count":1},{"time":"20250810","count":1},{"time":"20250811","count":2},{"time":"20250814","count":1},{"time":"20250818","count":1},{"time":"20250819","count":1},{"time":"20250820","count":1},{"time":"20250825","count":1},{"time":"20250827","count":1},{"time":"20250829","count":1},{"time":"20250902","count":2},{"time":"20250904","count":2},{"time":"20250905","count":1},{"time":"20250909","count":1},{"time":"20250911","count":1},{"time":"20250916","count":1},{"time":"20250919","count":1},{"time":"20250923","count":1},{"time":"20250924","count":1},{"time":"20251002","count":1},{"time":"20251003","count":1},{"time":"20251010","count":2},{"time":"20251014","count":1},{"time":"20251019","count":1},{"time":"20251021","count":1},{"time":"20251023","count":1},{"time":"20251028","count":1},{"time":"20251031","count":2},{"time":"20251103","count":1},{"time":"20251105","count":1},{"time":"20251107","count":1},{"time":"20251113","count":1},{"time":"20251121","count":1},{"time":"20251128","count":1},{"time":"20251129","count":1},{"time":"20251204","count":1},{"time":"20251211","count":1},{"time":"20251217","count":1},{"time":"20251229","count":1}],"recentPublications":[{"pmid":"41980582","title":"Silver sulfadiazine-cerium nitrate burn wound foam dressing stabilizes eschar by reducing local inflammation and controlling burn wound infections.","authors":"Karna SLR, Kiamco MM, Sebastian EA, Fourcaudot AB, Chen P","journal":"Burns","pubDate":"2026 Apr 8"},{"pmid":"41906850","title":"Time-dependent effects of topical mucopolysaccharide polysulfate and silver sulfadiazine on wound healing in a rat excisional wound model.","authors":"Dalaslan RE, Yücel MO, Sağlam S, Arıcan M, Karaduman ZO","journal":"Jt Dis Relat Surg","pubDate":"2026 May 1"},{"pmid":"41889582","title":"A randomized open-label study comparing the safety and efficacy of a natural antimicrobial dressing with silver sulfadiazine in the management of second-degree burn wounds.","authors":"Gayen S, Javalli SB, Pandey S","journal":"Int J Burns Trauma","pubDate":"2026"},{"pmid":"41862967","title":"Efficacy and Safety of Silver Sulfadiazine Dressings and Nanocrystalline Silver Dressings on Burns: A Systematic Review and Meta-Analysis.","authors":"Chen Z, Wu C, Zeng L, Li X, Gan Q","journal":"J Clin Nurs","pubDate":"2026 Mar 20"},{"pmid":"41842851","title":"Observation on the Efficacy of Nano-Silver Dressing Combined With Silver Sulfadiazine Cream in the Treatment of Second-Degree Burn Wounds.","authors":"He Q, Jiang W, Qu H, Zhang N, Zhang Y","journal":"J Craniofac Surg","pubDate":"2026 Mar 16"},{"pmid":"41742487","title":"Effectiveness of silver sulfadiazine-coated catheters in preventing thrombophlebitis in hospitalized foals.","authors":"Olivier M, Vanderstock J, Hermange T, Richard E, Picandet V","journal":"J Vet Intern Med","pubDate":"2026 Jan 21"},{"pmid":"41725469","title":"Silver sulfadiazine in modern dermatology.","authors":"Chalupczak N, Duong JQ, Jorizzo J, Feldman SR","journal":"Dermatol Online J","pubDate":"2025 Nov 14"},{"pmid":"41480126","title":"Re-Epithelialization Comparison Between Topical Administration of 1% Feracrylum and Silver Sulfadiazine in the Treatment of Deep Dermal Burns in Wistar Rats.","authors":"Hermawan DR, Nahusuly F, Josh F, Kasim F, Faruk M","journal":"Ann Burns Fire Disasters","pubDate":"2025 Dec"},{"pmid":"41244456","title":"Bioinspired Membranes with Silver Sulfadiazine and Piperine for Enhanced Cutaneous Permeability.","authors":"de Deus GCB, Doring HD, Ricken YS, Dotto MER, Galvan D","journal":"ACS Omega","pubDate":"2025 Nov 11"},{"pmid":"41012569","title":"Laponite(®)-Based Smart Hydrogels for Sustained Topical Delivery of Silver Sulfadiazine: A Strategy for the Treatment of Contaminated or Biofilm-Forming Wounds.","authors":"do Nascimento JL, da Costa MCV, de Macêdo LF, de Macêdo LHC, de Moura RO","journal":"Pharmaceutics","pubDate":"2025 Sep 22"}],"rxnormFormulations":[{"tty":"SBD","name":"silver sulfadiazine 10 MG/ML Topical Cream [SSD]","rxcui":"208185","synonym":"SSD 1 % Topical Cream"},{"tty":"SBD","name":"silver sulfadiazine 10 MG/ML Topical Cream [Silvadene]","rxcui":"208186","synonym":"Silvadene 1 % Topical Cream"},{"tty":"SBD","name":"silver sulfadiazine 10 MG/ML Topical Cream [Thermazene]","rxcui":"208187","synonym":"Thermazene 1 % Topical Cream"},{"tty":"SBD","name":"enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension [Enrosite Silver]","rxcui":"2704946","synonym":"Enrosite Silver (enrofloxacin 0.5 % / silver sulfadiazine 1 % ) Otic Suspension"},{"tty":"SBD","name":"enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Solution [Enropro Silver]","rxcui":"2712624","synonym":"EnroPro Silver (enrofloxacin 0.5 % / silver sulfadiazine 1 % ) Otic Solution"},{"tty":"SBD","name":"enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Solution [Baytril Otic]","rxcui":"894772","synonym":"Baytril Otic (enrofloxacin 0.5 % / silver sulfadiazine 1 % ) Otic Emulsion"},{"tty":"SCD","name":"silver sulfadiazine 10 MG/ML Topical Cream","rxcui":"106351","synonym":"silver sulfadiazine 1 % Topical Cream"},{"tty":"SCD","name":"enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Suspension","rxcui":"2704941","synonym":"enrofloxacin 0.5 % / silver sulfadiazine 1 % Otic Suspension"},{"tty":"SCD","name":"enrofloxacin 5 MG/ML / silver sulfadiazine 10 MG/ML Otic Solution","rxcui":"894768","synonym":""}],"storageAndHandling":"","participantFlowData":[],"companionDiagnostics":[],"faersSexDistribution":[{"term":2,"count":1175},{"term":1,"count":856},{"term":0,"count":3}],"genericManufacturers":0,"_genericFilersChecked":true,"nonclinicalToxicology":"Carcinogenesis, Mutagenesis, Impairment of Fertility. Long-term dermal toxicity studies of 24 months duration in rats and 18 months in mice with concentrations of silver sulfadiazine three to ten times the concentration in silver sulfadiazine cream, USP 1% revealed no evidence of carcinogenicity.","structuredTrialResults":[],"genericManufacturerList":[],"faersSeriousnessBreakdown":[{"term":1,"count":1437},{"term":2,"count":753}],"status":"approved","companyName":"King Pharms Llc","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"1973","enrichmentLevel":5,"visitCount":9,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"Un","currency":"USD","price_amount":"29.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"29.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"29.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"29.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null},{"country_code":"UN","currency":"USD","price_amount":"29.00","price_per":"year","price_type":"NADAC","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":17,"withResults":4},"validation":{"fieldsValidated":4,"lastValidatedAt":"2026-04-20T08:27:01.952015+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}